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THE CHALLENGE OF CANCER CHEMOTHERAPY 
Alfred Gellhorn, M.D. 
(From the Medical Service, Francis Delafield Hospital, and the Department of 
Medicine, College of Physicians and Surgeons, Columbia University, New York) 
This address was delivered at Washington University School of Medicine, St. Louis Mo on 
March 7, 1951, as the second M. G. Seelig Lecture, in honor of Dr. Major G. Seelig professor 
emeritus of clinical surgery.   Dr. Gellhorn is a 1937 graduate of Washington University School 
of Medicine. 
It is a privilege to participate with 
you in this expression of affection and 
respect for Dr. Major Seelig. Dr. 
Seelig's boundless energy, keen insight 
and broad experience brought him to 
preeminence in both clinical surgery 
and scientific research. Dr. Graham has 
reviewed some of the medical contribu- 
tions made by Dr. Seelig, and many of 
us in a variety of medical disciplines 
have made use of the knowledge that 
tie added. Besides the well-deserved rec- 
3gnition that Dr. Seelig has won in his 
jrofession, it is also to be recalled that 
his stature was great as a citizen of this 
community. To mention but a few of 
Dr. Seelig's extrascientific activities, we 
can remember that he was a founder of 
the Liberal Forum, an important me- 
dium of adult education in St. Louis; 
and he was a long- time and construc- 
tive member of the Public Library 
Board. As a member of the Social 
Planning Council and founder of the 
Blue Cross Hospitalization Insurance 
Dlan, he gave generously and skillfully 
of  his  talents  toward  the  solution  of 
broad economic, social, and health 
problems of this city. As a tireless 
worker on the Board of the People's 
Hospital, Dr. Seelig made a major con- 
tribution to the improvement of com- 
munity relationships. This only partial 
list of Dr. Seelig's activities is an im- 
pressive measure of the man, and the 
work that he has done is a living memo- 
rial to him. 
Dr. Seelig recognized many chal- 
lenges in his professional and commu- 
nity life and met them successfully. To- 
night I wish to discuss with you one 
phase of a problem which bristles with 
challenges. 
THE CHALLENGE OF CANCER 
CHEMOTHERAPY 
The chemotherapy of cancer is ages 
old. Long before the development of 
the techniques of radical surgery and 
the methods of irradiation, malignant 
disease was treated by drugs in a variety 
of forms. The approach was character- 
ized by the application of naive and 
erroneous concepts and the therapeutic 
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results were uniformly bad. When it 
was demonstrated that certain malig- 
nant diseases could be cured by surgery 
and/or radiotherapy and when critical 
laboratory and clinical evaluations were 
made of cancer remedies such as crab 
soup, purgation, blood-cleansing po- 
tions, heavy metals externally and in- 
ternally administered and black or red 
pastes, cancer chemotherapy fell into 
well justified disrepute. 
During the past half-century, how- 
ever, the accumulated experience with 
conventional surgical and irradiation 
treatment has taught the medical pro- 
fession that there still is a desperate 
need for additional therapeutic weap- 
ons in the management of human ma- 
lignancy. With this realization atten- 
tion is once again focused on the poten- 
tialities of chemotherapy and vast ef- 
forts in this field are in progress. 
A powerful stimulus to research in 
cancer chemotherapy has been the dra- 
matic successes achieved by anti-micro- 
bial chemotherapy. The demonstration 
that a chemical compound can selec- 
tively destroy an invading micro-organ- 
ism has spurred the hope that a similar 
effect on the neoplastic cell may be 
achieved. Sober reflection of the com- 
parative difficulties posed by the ther- 
apy of infection and of cancer leads to 
the realization that there are a number 
of fundamental differences in the two 
problems. Probably the most striking 
difference is that in microbial infections 
the offending invader is foreign to the 
host and efficient defense mechanisms 
provide strong support to supplement 
and complement the effects of thera- 
peutic drugs; the malignant cell, on the 
other hand, is qualitatively indistin- 
guishable from the normal cells of the 
body and no innate restrictive defenses 
are mobilized against it. A distin- 
guished scientist who had devoted his 
life to experimental cancer research 
took cognizance of the basic difficulties 
which theoretically raise the odds im- 
pressively against successful chemother- 
apy of malignant disease when he said 
that the problem of treatment with 
chemical compounds is "almost — not 
quite, but almost—as hard as finding 
some agent that will dissolve away the 
left ear, yet leave the right ear un- 
harmed : so slight is the difference be- 
tween the cancer cell and its normal 
ancestor." 
In spite of the obvious obstacles to 
a chemotherapeutic solution of cancer 
and in spite of the understandable skep- 
ticism of many, the challenge presented 
by the practical problem of the med- 
ical management of disseminated malig- 
nant disease is so great that all efforts 
must be made to meet it. Tonight I wish 
to evaluate with you some phases of 
modern cancer chemotherapy to deter- 
mine whether there are as yet any 
auspicious signs for the future. 
At this time it must be recognized 
that there are no drugs now available 
which completely eradicate any malig- 
nant disease. There are, however, chem- 
ical compounds which modify the 
course of certain malignant tumors and 
which are indicated in the clinical care 
of patients with these tumors. 
The important observations of Hug- 
gins and his associates, which led to the 
recognition that malignant prostatic epi- 
thelium requires male sex hormone for 
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its survival, have firmly established es- 
trogens as a part of androgen-control 
therapy of disseminated cancer of the 
prostate. Both estrogens and androgens 
have found application in the palliative 
treatment of metastatic breast carci- 
noma and the relief of bone pain, 
improvement in appetite and sense of 
well-being which may follow their ad- 
ministration is of significant importance 
to the patient. The pituitary adrenal 
cortical stimulating hormone and corti- 
sone have been found to produce re- 
missions in acute leukemia, particularly 
of children, with some regularity and 
have also been reported to benefit pa- 
tients with lymphomas and multiple 
myeloma. Urethane may substitute for 
radiotherapy in the treatment of chronic 
leukemias and perhaps more impor- 
tantly it can be used to modify the 
course of multiple myeloma in a signif- 
icant proportion of cases. The judicious 
use of the nitrogen mustards in conjunc- 
tion with radiotherapy offers significant 
palliation to patients with Hodgkin's 
diseases, lymphosarcoma and broncho- 
genie carcinoma. Finally, the folic acid 
antagonists have the distinction of being 
the first therapeutic weapons ever to 
alter the course of acute leukemia. 
It is neither feasible nor pertinent to 
discuss the laboratory and clinical data 
on each of these chemotherapeutic com- 
pounds. Rather I will present a brief 
summary of the biological actions on 
normal and tumor cells produced by 
two of the drugs, followed by the story 
of a chemical compound which we are 
studying in the laboratory. This, it is 
hoped, will provide orientation to the 
present status of cancer chemotherapy. 
Let us consider first the nitrogen mus- 
tards which were introduced into the 
therapeutic management of malignant 
disease by Gilman and Goodman at 
Yale and Jacobson and Spurr at the 
University of Chicago in 1942. The de- 
velopments which led to the clinical 
study of this agent are closely linked to 
the history of dichloroethyl sulfide, the 
dreaded "mustard gas" of World War I. 
In 1886 a German chemist, Victor 
Meyer, described the properties of this 
latter compound. Meyer appreciated 
the highly toxic local actions of the sul- 
fide because he and his associates in 
the laboratory sustained severe skin 
contact-burns from working with the 
chemical compound; in addition, Meyer 
noted that following the administration 
of small doses parenterally to rabbits, 
the material produced death rapidly. 
The toxicological properties of this 
compound were disregarded until the 
first World War. 
During the spring of 1917, however, 
the Germans carried out secret field 
tests with such satisfactory results that 
they adopted dichloroethyl sulfide as 
an artillery shell filling and accumu- 
lated a large quantity of these (yellow 
cross) shells without the knowledge or 
at least understanding of Allied intelli- 
gence. On the night of July 12, 1917, 
the Germans bombarded the British po- 
sitions near Ypres in Flanders with 
these shells. The devastating effects 
produced by this unexpected chemical 
offensive warfare are indicated by the 
statistics of 14,276 casualties processed 
through British casualty stations in the 
first three weeks of mustard gas use. 
Descriptions of sulfur mustard intox- 
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ication soon appeared in the medical 
literature, with initial attention focused 
on the local actions as manifested by 
skin vesication progressing to deep 
ulceration, conjunctivitis, photophobia 
and lacrimation; irritative laryngitis, 
bronchitis with intractible cough and 
aphonia; secondary bronchopneumonia 
associated with severe damage to alve- 
olar epithelium, massive pulmonary 
edema and death. Somewhat later, how- 
ever, serious systemic toxicity was rec- 
ognized as a major complication of 
mustard intoxication and descriptions of 
profound hemopoietic depression, dis- 
solution of lymphoid tissues and gastro- 
intestinal ulceration were recorded. 
Laboratory studies to define the mecha- 
nism of cytotoxic action were under- 
taken, but the termination of World War 
I led to the discontinuation of these 
investigations before a careful evalua- 
tion of the problem had been com- 
pleted. 
In the interim between World Wars 
I and II only scattered studies on the 
biological effects of sulfur mustard 
were reported; however, there was con- 
tinued activity in the chemical warfare 
laboratories of the French and Germans 
directed toward the discovery of more 
toxic agents. With the advent of the 
Second World War new compounds 
were proposed as potential offensive 
agent. Sulfur mustard shared interest 
with a series of nitrogen analogs, bis- 
and tris-(B-chloroethyl)-amines. It was 
rapidly demonstrated that the nitrogen 
mustards were also contact vesicants 
and careful pathological studies re- 
vealed the cytotoxicity of these com- 
pounds on a number of tissues follow- 
ing their absorption. As had been noted 
in the studies with sulfur mustard, 
lymphoid structures were especially 
susceptible to damage by the nitrogen 
mustards. These observations, coupled 
with the fact that the hydrochloride 
salts of the nitrogen mustards were crys- 
talline compounds, thereby facilitating 
their handling, led the groups at Yale 
and Chicago to explore the therapeutic 
possibilities of these agents in the ma- 
lignant lymphomas. 
The biological actions of the nitrogen 
mustards are impressively demonstrated 
following the administration of mini- 
mum lethal doses to dogs. The delayed 
lethal syndrome thus produced is of 
real pertinence to the clinician usinsr 
nitrogen mustard. The events which 
characterize this syndrome are encom- 
passed within three to seven days and 
either result in death of the experimen- 
tal animal or uneventful recovery. Ano- 
rexia is evident in the first day follow- 
ing the injection of the drug and per- 
sists throughout the period. Associated 
with this there is loss of weight which 
exceeds, however, the effect of starva- 
tion alone. Usually profuse vomiting 
occurs within several hours after intox- 
ication and continues for two or three 
days. On the third day there is the 
onset of diarrhea which progresses to 
ulceration of the gastrointestinal tract 
with large losses of fluid, electrolytes 
and blood. The syndrome is compli- 
cated by marked depression of hema- 
topoiesis manifested by progressive 
lymphopenia, granulocytopenia and 
thrombopenia. Complex disturbances 
of electrolyte and water metabolism are 
also   in   progress   with   loss   of   intra- 
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cellular potassium and cellular dehy- 
dration. Terminally, there is hypother- 
mia and shock, followed in several 
hours by coma and respiratory failure. 
The precise cause of death in nitro- 
gen mustard intoxicated animals is un- 
derstandably obscure. The disruptions 
of physiological function produced by 
the hemorrhagic necrosis of the gastro- 
intestinal tract, by aplasia of the bone 
marrow, and by alterations of electro- 
lyte and water distribution due to toxic 
effects on cells, as well as possibly on 
renal transport systems, are great and 
interrelated. The entire problem of the 
mechanism of lethal nitrogen mustard 
toxicity is further complicated by the 
fact that correction of the obvious ab- 
normalities by appropriate substitution 
therapy in the form of transfusions, 
electrolyte solutions and so on fails to 
prevent the lethal outcome. This sug- 
gests that subtle toxic efforts on the 
cells are produced which irreparably 
damage their function. 
The toxic manifestations and patho- 
logical changes produced by nitrogen 
mustard resemble in many details the 
effects of total body x-irradiation. The 
radiomimetic actions of the chemical 
compound accounts, in part, for the 
great efforts that have been put forth to 
alii discover its intimate mechanism of ac- 
ini tion because it has been hoped that the 
understanding thus gained would shed 
light on cellular effects produced by 
ionizing radiation. 
Turning to the actions of nitrogen 
mustard in man it may be broadly 
stated that therapeutic doses produce 
effects comparable to total body ir- 
radiation.   As was anticipated from the 
observations of the susceptibility of 
lymphoid tissues to this chemical com- 
pound, the most successful therapeutic 
application has been in the management 
of the malignant lymphomas. In pa- 
tients with these tumors, and most strik- 
ingly in cases of disseminated Hodg- 
kin's disease, dramatic reversal of the 
lesions can be achieved by the admin- 
istration of nitrogen mustard. There can 
be no doubt of the fundamental effects 
of this drug on neoplastic cells when 
one observes patients with high fever, 
marked weakness and anorexia, gen- 
eralized Iymphadenopathy, and enlarge- 
ment of the liver and spleen who, forty- 
eight hours after an intravenous course 
of nitrogen mustard, have normal tem- 
peratures, subjective improvement, a 
voracious appetite and then a more 
gradual regression of tumor infiltra- 
tions. Unfortunately the remissions so 
induced are only temporary. Why is it 
not possible to eradicate these suscep- 
tible tumors? The limitation to effec- 
tive therapy rests on the fact that nitro- 
gen mustard has no true selectivity of 
action on neoplastic cells. This drug 
has a devastating effect on the cellular 
function of normal and malignant tis- 
sues in direct proportion to the rate of 
proliferation of these cells. Thus, be- 
cause of the high turn-over rate of the 
cells of the hemopoietic system, even 
when therapeutic doses of nitrogen mus- 
tard are given, depression of bone mar- 
row function is manifested by lympho- 
penia, granulocytopenia and thrombo- 
penia. Complete destruction of a tumor 
by nitrogen mustard would also destroy 
the host. 
Here,    then,    we    meet    the    basic 
88 WASHINGTON UNIVERSITY 
problem of cancer chemotherapy head- 
on. The nitrogen mustards interfere 
with a mechanism of the malignant cell 
but this mechanism is also vital to the 
function of normal cells. Under these 
circumstances* it is obvious that only 
limited therapeutic objectives can be 
attained. But what are these fundamen- 
tal cellular mechanisms and what can 
we learn about them which may be of 
value in further chemotherapeutic re- 
search ? 
During World War II extensive inves- 
tigations were conducted on the mecha- 
nism of action of nitrogen mustard with 
the objective of devising rational anti- 
dotal measures. A major contribution 
was made by chemists who demon- 
strated that the chemical compound 
underwent an intramolecular transfor- 
mation when placed in solution at the 
pH of body fluids. The compound thus 
formed was shown to be highly reactive 
chemically. Biochemists then found that 
a large number of compounds of biolog- 
ical importance reacted with nitrogen 
mustard in the test tube. These included 
such varied substances as amino acids, 
proteins, vitamins and a number of 
enzymes. The concentrations of the 
drug required to alter these entities, 
however, were far greater than oc- 
curred in vivo, even following the ad- 
ministration of lethal doses, and there- 
fore it was considered unlikely that 
inactivation of any of these substances 
accounted for the observed biological 
actions. Increasing evidence from bio- 
chemical, histochemical, genetic and 
morphological studies has focused at- 
tention on the nucleic acids as the pri- 
mary  site  of  action  of  the  mustards. 
Brilliant cytological experiments at the 
Chester Beatty Institute in London and 
at the Wilmer Institute in Baltimore 
have demonstrated mitotic inhibition of 
cells exposed to extremely low concen- 
trations of nitrogen mustard and spe- 
cific alterations of chromosomal struc- 
ture could be detected and characterized 
in these cells. Since it has been estab- 
lished that the chromosome is a com- 
plex nucleoprotein in which the desoxy- 
pentose nucleic acid is the chief poly- 
nucleotide, the morphological evidence 
suggests that the mustards may react 
with these latter important nuclear con- 
stituents. The induction by the mus- 
tards of heritable mutations in the fruit 
fly and in certain fungi also provides 
convincing proof that the drug alters 
chromosomal function. The inactivation 
of viruses, particularly those rich in 
desoxypentose nucleic acid, the change 
in viscosity of DNA from thymus and 
the evidence from dynamic studies, 
which indicates suppression of desoxy- 
pentose nucleic acid synthesis all pro- 
duced by the mustards, provide addi- 
tional support to the tentative conclu- 
sion that the drug destroys cells by 
interfering with the functions of the 
nucleic acids. 
Before trying to draw any lesson 
learned from the clinical and basic in- 
vestigations of the nitrogen mustards 
let us review briefly the current status 
of knowledge about another group of 
cytotoxic agents, the folic acid analogs. 
These compounds, which are very 
closely related chemically to pteroylglu- 
tamic acid, or folic acid, are noteworthy 
because they can produce remissions in 
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their mechanism of action have illumi- 
nated some fundamental aspects of cel- 
lular physiology. There are a number 
of folic acid analogs which have been 
synthesized and studied in the labora- 
tory and in the clinic. Although they 
vary in potency, their biological actions 
are qualitatively identical and therefore 
we will typify them all in discussing 
just one of them, aminopterin. 
The toxicity of the folic acid analogs 
in experimental animals has been care- 
fully studied in order to throw light on 
the mechanism of action of the drugs 
and in order to anticipate the hazards 
in their clinical application. Animals 
receiving single, fatal doses of aminop- 
terin, survive for at least 48 hours and 
usually succumb between the third and 
fifth day. The characteristic syndrome 
of toxicity is manifested by progressive 
weight loss, anorexia, bloody diarrhea, 
leucopenia, depression, terminal col- 
lapse and coma. 
As could be anticipated from the clin- 
ical course of fotal intoxication with the 
drug, the chief pathological changes 
have been found in the intestinal tract 
and the bone marrow. Microscopic ex- 
amination of the small and large intes- 
tine reveals swelling and cytoplasmic 
vacuolization of the epithelium as early 
as six hours after the parenteral admin- 
istration of the drugs. The initial 
changes are followed by desquamation 
of the epithelial calls, plasma extravasa- 
tion into the intestinal lumen and inten- 
sive leucocytic infiltration of the sub- 
mucosa. Within three days after acute 
poisoning or within a somewhat longer 
period after chronic intoxication, the 
whole mucous membrane from the duo- 
denum to the anus is edematous, swol- 
len, and in part, hemorrhagic. 
On the third day of acute intoxica- 
tion, the bone marrow of the experi- 
mental animals is found to be grossly 
abnormal. The peripheral blood showed 
marked granulocytopenia retriculocyto- 
penia, and moderate lymphopenia. Se- 
rial examination of the bone marrow 
reveals progressive depletion of all cells 
in the erythroid and myeloid series. 
Apart from the lesions of the bone 
marrow and the intestines, no outstand- 
ing pathological changes have been 
noted. Decrease in the size of lymph 
nodes and spleen has been described but 
histological studies have not revealed 
striking cytotoxicity to lymphoid cells. 
In humans the biological actions of 
aminopterin can be excitingly demon- 
strated when a remission is induced in a 
child dying from acute leukemia. In 
those patients who respond, the abnor- 
mal immature leucocytes in the pherph- 
eral blood and bone marrow may 
completely disappear to be replaced by 
normal mature forms. Associated with 
this change, the anemia and thrombocy- 
topenia may be corrected by a spon- 
taneous rise of the erythrocytes and 
platelets. Hermorrhagic manifestations 
cease, the hectic temperature curve re- 
turns to the baseline, the child begins 
to eat with relish and to react to his 
surroundings and associates with re- 
newed vigor and pleasure; bone pain 
and other objective signs of the leu- 
kemic process such as peripheral 
lymphadenopathy and gross visceral in- 
filtrations disappear. Within a period 
of two weeks a critically ill child may 
once again be in good health. 
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As you well know, the story can not 
be ended here. The response just de- 
scribed is observed in only about one 
third of the cases. Another group, com- 
prising about 20 per cent of the total, 
show only a moderate hematologic re- 
sponse but are nevertheless markedly 
improved symptomatically. The remain- 
ing half of the patients suffer a severe 
initial bone marrow depression follow- 
ing the administration of aminopterin 
and hemorrhagic phenomena occur 
which, along with the depredations of 
the disease, contribute to death early in 
the course of treatment. 
There are several points which have 
emerged from the clinical studies with 
the folic acid analogs which merit atten- 
tion. As has been stated, only about 50 
percent of children with acute leukemia 
show a favorable response. It is im- 
possible a priori to predict which pa- 
tient will have a remission; this sepa- 
ration of acute leukemias into those 
which are and those which are not con- 
trolled by aminopterin presents a fas- 
cinating problem in the biology of the 
disease. Another striking observation 
along this line is that the results of 
aminopterin therapy in acute leukemia 
of adults are far less satisfactory than 
in the childhood disease. It is possible 
that the therapeutic drug will also serve 
as a tool for investigating these biolog- 
ical enigmas when its mechanism of 
action is more fully understood. 
It has been implied that the folic acid 
analogs do not cure acute leukemia. 
This is true, and further, experience has 
taught us that with each exacerbation of 
the disease, the response to therapy is 
less   evident  until  sooner  or  later  no 
effect can be detected. Recent experi- 
mental studies by Law and by Burch- 
enal have demonstrated that the devel- 
opment of refractoriness to the folic 
acid analogs is an inherent response of 
the leukemic cell. Whether this is the 
acquisition or enhancement of a cellu- 
lar detoxifying mechanism or whether 
an alternate metabolic pathway is de- 
veloped which bypasses the function 
affected by the folic acid analogs is not 
yet known. 
Finally, clinical studies have empha- 
sized the important toxicity of the folic 
acid analogs on normal cells. The cells 
of the hematopoietic system and the 
epithelium of the alimentary tract are 
particularly susceptible. Severe bone 
marrow depression, ulcerative stomatitis 
and hemorrhagic enteritis are not infre- 
quent concomitants of therapeutic doses 
of these powerful drugs. 
Again we must recognize that ami- 
nopterin fails to provide the solution to 
a therapeutic problem of malignant dis- 
ease. The drug does have some pro- 
found effect on malignant cells, how- 
ever, and therefore it is important to 
know how it acts. 
When the folic acid analogs were 
first synthesized their biological action 
was studied on bacteria which required 
folic acid for growth. In these micro- 
biological experiments aminopterin was 
found to inhibit the growth of appro- 
priate bacteria and its action could be 
reversed by the addition of more folic 
acid to the medium. This led naturally 
to the conclusion that aminopterin and 
related compounds were folic acid an- 
tagonists. This concept began to be 
seriously questioned, however, when it 
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was found that both in experimental 
animals and in man, folic acid had only 
limited success in preventing the tox- 
icity of its analogs. If toxic manifesta- 
tions had already appeared following 
the administration of aminopterin, then 
folic acid was completely ineffective in 
reversing them. These observations sug- 
gested that aminopterin was an antag- 
onist of folic acid, but in addition 
caused cytotoxicity through some un- 
related mechanism. As we shall see, 
recent advances in our knowledge of the 
biochemical function of folic acid and 
of its metabolism indicate that the puz- 
zling discrepancies just mentioned can 
be adequately explained on a single 
basis. 
From exciting observations made on 
microbiological systems and in bio- 
chemical experiments using radiocarbon 
and heavy nitrogen tagged molecules, 
evidence has been accumulated which 
points to the nucleic acids as the cellular 
components affected by the folic acid 
analogs. Since our knowledge of the 
mechanism of action of these drugs is 
more precise than in the case of nitro- 
gen mustards, it will be profitable to 
review briefly and schematically some 
aspects of nucleic acid metabolism. 
In figure 1 there is represented dia- 
grammatically the sequence of events 
which lead to the synthesis of nucleo- 
proteins. This is an over simplification, 
but it will facilitate the presentation of 
the probable sites of action of the folic 
acid analogs. As can be seen, from the 
simple precursors glycine, ammonia and 
active single carbon fragments such as 
formate, the far more complex purine 
and  pyrimidine  molecules  are synthe- 
sized. The nucleic acids are built up 
from combinations of purines and pyri- 
midines to each of which there is added 
a 5-carbon sugar moiety, either a pen- 
tose or a desoxypentose, and phos- 
phorus. It is known that the nucleic 
acids are complex polynucleotides, i.e., 
molecules of purine plus sugar and 
pyrimidine plus sugar joined together 
through phosphoric acid ester linkages. 
The formation of the high molecular 
weight nucleoprotein, is accomplished 
by the addition of a protein to the 
nucleic acid. Exact definition of the 
protein component and the mechanism 
of its condensation with nucleic acids 
are areas which are being investigated 
in many laboratories here and abroad. 
How does aminopterin enter into this 
picture? In figure 2 there are indicated 
three metabolic functions which are 
blocked by folic acid deficiency either 
due to inadequate dietary intake of the 
vitamin or to administration of the anti- 
vitamin, aminopterin. In the first ex- 
ample is pictured the reversible reaction 
in which the amino acid serine is synthe- 
sized from glycine plus a single carbon 
fragment, or in which serine is broken 
down into glycine and an active carbon 
fragment. Folic acid is a part of the 
enzyme system which catalyzes the re- 
action, and the reaction can be blocked 
by aminopterin. As you will remember, 
glycine is one of the precursors of the 
purines and pyrimidines so that inter- 
ference with its availability would seri- 
ously hamper nucleic acid synthesis. 
The second illustration of a site of 
aminopterin action requires a little am- 
plification. During the past few years 
evidence  has  been  accumulated  which 











Figure  1.   Diagrammatic  representation  of 
nucleoprotein synthesis. 
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indicates that folic acid is converted in 
the animal organism to a related form 
which is biologically active. This al- 
tered folic acid is called the "citrovorum 
factor" because a bacterial species, Leu- 
conostoc citrovorum, requires it for 
growth. More recently, chemical char- 
acterization of the "citrovorum factor" 
indicates that it is a reduced form of 
folic acid which has been named folinic 
acid. When folic acid is given to hu- 
mans there is a proportional excretion 
in the urine of folinic acid or the citro- 
vorum factor. Welch has shown that 
when rat liver slices are incubated with 
folic acid, the citrovorum factor ap- 
pears in the medium. This in vitro con- 
version of folic acid to folinic acid is 
blocked by the addition of aminopterin. 
When it was found that the citrovorum 
factor or folinic acid could prevent the 
toxicity of aminopterin and also could 
reverse toxic manifestations produced 
by the drug, a reasonable explanation 
for the inability of folic acid to accom- 
plish these ends was apparent. Thus 
aminopterin, by blocking the conversion 
of folic acid to the active folinic acid, 
effectively stifles the formation of its 
own inhibitor. 
Finally, as shown in C. of the figure, 
evidence has been obtained which im- 
plicates folinic acid as a part of the 
enzyme system necessary for the syn- 
thesis of the purine nucleus. The par- 
ticular step consists of the introduction 
of a carbon atom between two nitro- 
gens, thus completing the purine nu- 
cleus. Aminopterin blocks this impor- 
tant synthetic process, thereby further 
interfering with nucleic acid metab- 
olism.   Whether there are further sites 
of action of aminopterin in the nucleo- 
protein synthetic chain is not yet 
known. Certainly the available evidence 
adequately demonstrates that the drug 
strikes at fundamental cellular mecha- 
nisms. 
From the stories just presented on 
the mechanisms of action of nitrogen 
mustard and aminopterin, it is not sur- 
prising that interest of many labora- 
tories working in the field of experi- 
mental cancer chemotherapy turned to 
the nucleic acids. The difficulties of 
interfering with nucleic acid function in 
neoplastic cells without affecting nor- 
mal cells has been highlighted in the 
preceding discussion. I would like to 
tell you, therefore, about a chemical 
compound which, as of this time at 
least, appears to circumvent the di- 
lemma. 
Some years ago Roblin synthesized a 
number of purine analogs and tested 
their anti-bacterial activity. Although 
several appeared promising, the advent 
of penicillin discouraged further studies 
along these lines. Two years ago 
Kidder, at Amherst, found that an ani- 
mal microorganism, Tetrahymena gelei, 
which he was studying, required the 
purine guanine for its growth. When 
he added, to the medium, a guanine 
analog which Roblin had previously 
prepared, the growth of the Tetrahy- 
mena was inhibited. Kidder then studied 
the action of the guanine analog on the 
growth of a number of other micro- 
organisms and also on several experi- 
mental tumors. He reported that the 
guanine analog inhibited the growth of 
these tumors. At that time our labora- 
tory was also exploring the chemothera- 
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peutic action of purine and pyrimidine 
analogs against experimental tumors. 
We confirmed and extended Kidder's 
observations and have become increas- 
ingly interested in the compound. 
In figure 3 are represented guanine 
and 8-azaguanine, the analog which in- 
hibits neoplastic growth. The type of 
response which this chemical produces 
is illustrated in figure 4, which shows 
the growth of an undifferentiated squa- 
mous cell carcinoma (the Brown-Pearce 
Carcinoma) growing in the anterior 
chamber of the eyes of treated and con- 
trol rabbits. We were particularly in- 
terested to note that the therapeutic 
effect was achieved without apparent 
host toxicity. This gross impression re- 
ceived additional support from studies 
of the effect of 8-azaguanine on the 
mitotic activity of normal and tumor 
tissue. This is shown in Table 1. Here 
it can be seen that the mitotic rate in 
the intestinal crypts and in the testes is 
the same in untreated and 8-azaguanine 
treated animals, whereas the mitoses of 
the tumor have been markedly de- 
pressed in treated rabbits. This indica- 
tion of tumor specificity was sufficient 
stimulus to learn more about the chem- 
ical compound. A further spur, how- 
ever, was our finding and that of others, 
that 8-azaguanine inhibited the growth 
of a variety of experimental epithelial 
tumors including squamous cell carci- 
noma and several mammary adenocar- 
cinomas in mice, but failed significantly 
to affect sarcomas, lymphosarcomas or 
leukemias. Because the drug was car- 
cinostatic, rather than carcinolytic, we 
had no inclination to give it clinical 
trial; however, the fact that it seemed to 
have selective action for tumor cells in 
contrast to normal cells, and also be- 
cause it had a selective action on a 
morphologically separate group of ma- 
lignant tumors, suggested that the chem- 
ical compound would be a splendid tool 
for studying biochemical differences be- 
tween normal and certain neoplastic 
cells and between cells of 8-azaguanine 
susceptible and resistant tumors. For 
this reason, a program of research on 
the mechanism of action of the drug has 
been initiated in our laboratory. 
This work is in progress and I am 
unable to give a complete story. How- 
ever, the results thus far illustrate a 
hopeful aspect for future cancer chemo- 
therapy, and therefore may be justifi- 
ably mentioned. Evidence which we, 
and also Skipper in Birmingham, have 
obtained, indicates that 8-azaguanine 
interferes with nucleic acid synthesis 
and nucleic acid function. The precise 
mechanisms involved are not yet known. 
THE EFFECT OF 8-AZAGUANINE ON THE MITOTIC RATE OF NORMAL AND 
NEOPLASTIC TISSUES IN RABBITS* 
Tumor 
(mitoses per 100 cells) 
Control   8.8 
8-azaguanine    1.1 
Intestine 




(mitoses per 100 cells) 
13.1 
14.7 
* Abstracted from: Shapiro, Weiss and Gellhorn.  Cancer 3: 896, 1950. 
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Treated Control Figure 4. The effect of 8-azaguanine treatment 
on the Brown-Pearce carcinoma transplanted 
to the anterior chambers of rabbits' eyes. The 
small numbers refer to periods after trans- 
plantation. The arrows indicate the tumor. 
Number 2 is immediately after transplanta- 
tion. Number 3 is two days later. Treatment 
started on the third day. Number 4 is 5 days 
after transplanation. Number 5 is 7 days after 
transplantation. Number 6 is 8 days after 
transplantation.    Number  7  is  10   days  after 
transplantation. 
Note that there is little growth of the tumor 
in   the   treated   animals,   whereas   the   tumor 
completely  fills  the  anterior  chamber  of  the 
control animals. 
(From Shapiro, Weiss and Gellhorn, 
Cancer 3: 896, 1950.) 
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We* do believe, however, that we have 
uncovered an important factor to ex- 
plain the observed differences in action 
of 8-azaguanine on normal and neo- 
plastic cells. An enzyme is present in 
normal tissue cells which deaminates 
8-azaguanine to the corresponding xan- 
thine analog, 8-azaxanthine. This re- 
action is illustrated in figure 5. When 
we determined the cellular concentra- 
tion of this enzyme in susceptible tu- 
mors we found it to be low, whereas in 
the resistant tumors thus far examined 
it was very much higher. These com- 
parisons are shown in figure 6, in which 
the concentration of the enzyme in the 
tumors is related to the level in the 
liver. This observation takes on signif- 
icance from toxicological and experi- 
mental chemotherapeutic studies in 
which we have shown that 8-azaxan- 
thine, the end product of the reaction 
catalyzed by this enzyme, is neither 
toxic nor does it have any growth-inhib- 
iting action on tumors. This leads us to 
the interpretation that 8-azaguanine in- 
hibits those tumors which are unable to 
convert the drug to the inactive form; 
normal cells and resistant tumors are 
protected by an efficient mechanism. 
Obviously, the observations discussed 
just now are not on the main road to 
the discovery of effective cancer chemo- 
therapy weapons. They do emphasize 
the application of an important fact. 
The fact is that there are many quanti- 
tative differences between normal and 
malignant cells even though qualitative 
differences have not yet been discov- 
ered. The application of this fact in the 
* Drs. E. Hirschberg, J. Kream, I. Jaffe, M. 
Gertler and J. Gang are all associated in this 
research work. 
case of 8-azaguanine is that the car- 
cinostatic action of the chemical com- 
pound can be directly related to the 
low concentration of a deaminating en- 
zyme in susceptible cells; in normal 
cells and in certain tumor cells both of 
which have a relatively higher concen- 
tration of the enzyme, no effect of the 
drug is demonstrable. 
The biochemists have shown that 
metabolite inhibition by an antimetabo- 
lite depends to a large degree upon 
the concentration of the metabolite; the 
relationship between enzymes and en- 
zyme inhibitors also follows this pat- 
tern. From the experience we have had 
with 8-azaguanine and from other ex- 
perimental observations in progress in 
our laboratory, we feel that the observed 
quantitative differences between normal 
and neoplastic cells may provide vul- 
nerable points for chemotherapeautic 
agents to attack cancer cell mechanisms. 
In summary, it has been noted that 
the impressive biological actions of the 
nitrogen mustards and the folic acid 
analogs are intimately related to their 
effects on nucleic acid metabolism and 
function. This reemphasizes the impor- 
tance of these cellular constituents and 
explains the interest of experimental 
cancer chemotherapeutists in this field. 
It has been indicated that these cytotoxic 
drugs do modify the course of certain 
malignant tumors and that they are use- 
ful in clinical medicine if their indica- 
tions and limitations are clearly recog- 
nized. The nitrogen mustards and ami- 
nopterin fail, however, to be truly effec- 
tive agents because they also are toxic 
to normal cells. This typifies the major 
problem of cancer chemotherapy. 
i'Jn 
:::a 
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Figure 5.   The intracellular enzymatic diami- 
nation of 8-azaguanine. 
Figure 6.   The ratio of cellular deaminase 
concentrations between tumor and liver. 
In the discussion of a chemical com- 
pound which is only of interest in ex- 
perimental cancer chemotherapy, evi- 
dence was presented which demonstrates 
the importance of quantitative differ- 
ences between normal and neoplastic 
cells in the attainment of a chemothera- 
peutic effect. It was suggested that the 
weakness of the neoplastic cell and the 
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illuminated by these quantitative, com- 
parative, biochemical characterizations, 
thereby providing guidance to the de- 
velopment of more effective anti-cancer 
drugs. 
The challenge of cancer chemother- 
apy is formidable but the progress of 
the past ten years offers auspicious signs 
that it will be met triumphantly. 
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WOHL HOSPITAL CONSTRUCTION STARTED 
Ten-Story Building to Add 82 Beds 
Construction on the $2,000,000 David 
P. Wohl, Jr., Memorial Hospital in the 
Medical Center was started during the 
last week of March. The architect's 
drawing of the hospital is reproduced 
above. 
The ten-story Wohl Hospital will be 
adjacent to the Nurses' Home and will 
connect with the Mallinckrodt Institute 
of Radiology and other nearby build- 
ings. Designed for a maximum of 82 
hospital beds and facilities for teaching 
and research, it is to be constructed so 
that three additional floors may be 
added in the future. 
Recent completion of the steel and 
concrete bridge across the Wabash Rail- 
road tracks made possible the begin- 
ning of construction on the hospital. 
The double-span bridge will provide a 
front entrance to the hospital from Au- 
dubon Avenue, and also will fill the 
long-felt need for a northern approach 
to the Medical Center. 
Offices for the Departments of Medi- 
cine and Surgery will occupy the second 
floor of the new hospital, with class- 
rooms and a lounge for students on the 
ground floor, and dining room and 
additional offices on the first floor. The 
third, fourth and fifth stories will be 
devoted to patient care, while the top 
five floors are to house offices and re- 
search laboratories for the surgery and 
medicine departments. 
Named in memory of Lt. David P. 
Wohl, Jr., the hospital is being built 
with funds provided in part by Mr. 
David P. Wohl, St. Louis shoe manu- 
facturer and philanthropist. Lt. Wohl 
was killed in a bombing raid over Ger- 
many in 1944. 
Mr. and Mrs. Wohl, the Wohl Foun- 
dation, and the Wohl Shoe Company 
contributed generously to finance the 
hospital, and the United States Public 
Health Service made a grant for the 
construction. 
Completion of the structure is ex- 
pected late in 1952. 
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W. U. to Admit First Negro 
to Medical School in Fall 
For the first time, a Negro has ful- 
filled the necessary qualifications and 
accepted admission to the regular four- 
year course in the School of Medicine. 
The student is Edgar R. Thomas of New 
York City and Kingston, Jamaica, Brit- 
ish West Indies, and he will enter with 
the 1951 freshman class in September. 
The School of Medicine was author- 
ized by the Board of Directors of the 
University in July, 1947, to admit Ne- 
groes on the same basis as all other 
students. There have been several Ne- 
groes in recent years who have taken 
postgraduate work in the Medical Cen- 
ter. 
Thomas is 30 years old, was born 
in New York City, and lived for several 
years in Jamaica, British West Indies, 
where he received his secondary educa- 
tion. He was employed by the Medical 
Department of Jamaica and was secre- 
tary to the senior medical officer of the 
Kingston Public General Hospital. 
In 1946 he entered Washington 
Square College of New York Univer- 
sity, and will receive his bachelor of 
arts degree from there in September. 
He has been working as a laboratory 
assistant in the chemistry department, 
and for two years has been president 
of the student affiliates of the American 
Chemical Society at NYU. 
Active in many University organiza- 
tions, Thomas was elected to the honor- 
ary pre-medical society, Caducean, and 
to the honorary German fraternity. Mrs. 
Thomas will accompany him to St. 
Louis. 
Markle Foundation Awards Third 
Scholarship to W. U. Researcher 
The John and Mary R. Markle Foun- 
dation announced in New York on 
March 4 the awarding of the third 
Markle Foundation scholarship to a 
research man at Washington University 
School of Medicine. The recipient is 
Dr. Robert B. King, fellow in neurolog- 
ical surgery now on leave of absence 
to do neurosurgical work at Walter 
Reed General Hospital in Washington, 
D. C. 
The School will receive a total of 
$30,000, to be made available at the 
rate of $6,000 for the next five years, to 
support Dr. King's research in neuro- 
surgery. Dr. King interned at Barnes 
Hospital following graduation from the 
University of Rochester School of Med- 
icine in 1946, and was a fellow and 
assistant resident in neuro-surgery on 
the staff here before leaving for army 
service in July, 1949. 
Dr. King is the third Washington 
University man to be named a "scholar 
in medical science" by the Markle Foun- 
dation. Dr. C. Barber Mueller '42, 
assistant in surgery, received such an 
appointment in 1949, and Dr. Ralph 
Smith in 1948. 
W. U. Commencement Changed 
Washington University commence- 
ments hereafter will be held on the 
Wednesday of the second week in June. 
The Calendar Committee voted to 
change the date permanently to avoid 
conflict with exercises of St. Louis Uni- 
versity. 
This change places the 1951 com- 
mencement on Wednesday, June 6. 
11 ; 
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W. U. to Be Host to International 
Gerontology Meeting in September 
Plans are well under way for the 
meeting of the Second International 
Gerontological Congress, which will 
meet in St. Louis at Hotel Jefferson, 
September 9 through 14. Dr. Edmund 
V. Cowdry, research professor of anat- 
omy, is president of the Congress and 
several other staff members of the Med- 
ical School are serving as chairmen of 
various committees. 
Washington University will act as the 
official host to the Congress. 
Activities will start on Sunday, Sep- 
tember 9, with setting up of exhibits 
and a radio broadcast of the University 
of Chicago Round Table from St. Louis. 
The exhibits will include 20 to 30 of a 
scientific nature and 60 in the commer- 
cial field. 
The Congress is being sponsored by 
the International Association of Geron- 
tological Societies, the Gerontological 
Society, Inc., and the American Geri- 
atrics Society. Four sections have been 
established for discussion of the phases 
of old age study. These are: biology 
and medicine; sociology, psychology, 
education and religion; economics and 
welfare; and medical services, hygiene 
and housing. 
More than one thousand delegates are 
expected to attend the Gerontological 
Congress, including representatives and 
diplomats from many foreign countries. 
1951 MEDICAL ALUMNI REUNION 
Friday Evening, June 1 
Guest Speaker: THE HONORABLE WALTER H. JUDD, M.D. 
Representative in United States Congress from the Fifth District, 
State of Minnesota. 
Dr. Judd returned to the United States in 1937 after several years 
as a medical missionary in China. He is a graduate of the Uni- 
versity of Nebraska School of Medicine, class of 1923. 
Place: STARLIGHT ROOF, CHASE HOTEL 
Kingshighway at Lindell, St. Louis 
Time: Cocktails, 6:30 P. M. Dinner, 7:00 P. M. 
The 1951 graduating class of the School of Medicine will be our 
guests on this occasion, so come and help give them a good 
send off! 
Please send your reservation to the Medical Alumni Office NOW! 
Your class will have its own table 
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Report of the Dormitory Fund 
Campaign 
Our immediate goal of $100,000 from 
the medical alumni is coming closer, 
but there is still some $35,000 outstand- 
ing before we can approach private 
philanthropy for contributions and 
really start work on the Medical Stu- 
dent Dormitory. 
The grand total of contributions and 
pledges is now $65,284.10, including 
$6500 in volunteer gifts from St. Louis 
friends of the Medical School, as men- 
tioned in the January QUARTERLY. The 
average gift from 707 donors stands at 
$92.00. 
There are still more than 2200 grad- 
uates of the Medical School who have 
not responded to our appeals. If you 
have not contributed yet, please send 
in your check now to show that you 
support this important project. 
Samuel B. Grant, Chairman 
1950—Living Graduates, 85 
Edward T. Emura, St. Louis 
Joseph D. O'Keefe, Nashville, Tenn. 
Robert I. Pfeffer, St. Louis 
Richard L. Swarm, St. Louis 
1949—Living Graduates, 96 
Roger Bumgarner, Kansas City, Kans. 
Eugene W. Pearce, Washington, D. C. 
Russell D. Sheldon, Kansas City, Mo. 
George S. Woodard, Jr., Washington, 
D. C. 
1948—-Living Graduates, 89 
Virgil R. Bleisch, Boston, Mass. 
Walter A. Fernau, Jr., Cincinnati, O. 
David A. Guterman, Elgin, 111. 
Hugh R. Harting, St. Louis 
Richard F. Huck, Jr., St. Louis 
Juro L. Shintani, Perry Point, Md. 
1947—Living Graduates, 98 
Charles G. Clay, Rantoul, 111. 
Marvin Cornblath, St. Louis 
William C. Dunckel, Charlottesville, Va. 
Helen Hofsommer Glaser, St. Louis 
Burnet W. Peden, St. Louis 
Virginia H. Peden, St. Louis 
1946—Living Graduates, 86 
Drennan Bailey, Clayton, Mo. 
R. Robert Bates, Tucson, Ariz. 
Gladden V. Elliott, Richmond Heights, 
Mo. 
Lawrence W. O'Neal, Webster Groves, 
Mo. 
James O. Owen, Jr., Skiatook, Okla. 
Theodore J. H. Smith, Temple, Tex. 
Robert S. Spain, McKinney, Tex. 
Frank Vellios, St. Louis 
Leonard J. Wiedershine, Aurora, Colo. 
1945—Living Graduates, 105 
John T. Farrar, Boston, Mass. 
Jay O. Gibson, French Camp, Calif. 
Samuel B. Guze, Newington. Conn. 
John T. Johnstone, Jr., St. Louis 
Donald E. Kilker, St. Louis 
Louis 0. Lambiotte, Salt Lake City, U". 
Ceylon S. Lewis, Jr., Salt Lake City 
Roscoe Maxwell, Punta Gorda, Fla. 
George W. Prothro, Clovis, N. Mex. 
Eugene T. Taylor, Mocksville, N. C. 
John W. Ubben, Staunton, 111. 
Gary B. Wood, St. Louis 
Betty Ben Geren, Boston, Mass. 
Charles Wolfson, Amarillo, Tex. 
1944—Living Graduates, 95 
Guy D. Callaway, Jr., Seattle, Wash. 
Albert B. Eisenstein, St. Louis 
J. K. Frost, Centralia, 111. 
Robert D. Lange, Kirkwood, Mo. 
Ervan Levine, Vandalia, Mo. 
Clayton H. Manry, Syracuse, N. Y. 
Francis E. Pennington, St. Louis 
H. H. Perman, Forest City, la. 
John J. Rupp, Tucson, Ariz. 
David E. Smith, St. Louis 
Roy A. Walther, Jr., Overland, Mo. 
Virgil Loeb, Jr., St. Louis 
Marvin T. Pursell, Dinuba, Calif. 
Louis Weisfuse, Brooklyn, N. Y. 
1943—(Dec.)—Living Graduates, 113 
John F. Blinn, Jr., Stockton, Calif. 
J. P. Myles Black, Olive View, Calif. 
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C. Read Boles, St. Louis 
William P. Callahan, Wichita, Kan. 
Joseph B. Clay, Van Nuys, Calif. 
Terrell Covington, Jr., McKinney, Tex. 
Edward W. Czebrinski, St. Louis 
Harold Grant, McKinney, Tex. 
Mary Jordan, Ridley Park, Pa. 
Walter J. Kennedy, Yakima, Wash. 
Edward H. Kowert, St. Louis 
Elaine K. Lince, Pasadena, Calif. 
Torrence A. Makley, Jr., Columbus, 0. 
Walter A. Rohlfmg, Fresno, Calif. 
Ernest Schwartz, San Francisco, Calif. 
Burton Shatz, St. Louis 
Donald E. Smith, Salt Lake City, U. 
Tom G. Stauffer, Scarsdale, N. Y. 
Herbert C. Wiegand, St. Louis 
Frances C. Wilson, Tampa, Fla. 
Carl T. Woolsey, St. Louis 
Alfred H. Sudholt, St. Louis 
Harold E. Walters, St. Louis 
1943—(March—Living Graduates, 105 
DeWayne C. Anderson, Stanhope, la. 
Grace E. Bergner, St. Louis 
Raymond M. Charnas, St. Louis 
David Feldman, St. Louis 
Harlan I. Firminger, Bethesda, Md. 
Melvin L. Goldman, St. Louis 
H. Clagett Harding, Portland, Ore. 
F. C. Lawrence, Bartlesville, Okla. 
Ira W. Liebner, Brooklyn, N. Y. 
Eichi Masunaga, T. H. 
Roberts B. Pappenfort, New York, N. Y. 
Ernest S. Rogers, San Francisco, Calif. 
Carvel T. Shaw, Hermann, Mo. 
David A. Stadtner, Stockton, Calif. 
H. A. Uhlemeyer, Jr., St. Louis 
Gerald J. Conlin, Denver, Colo. 
Albert N. Lemoine, Jr., Mission, Kans. 
James L. Petry, Port Arthur, Tex. 
Daniel G. Santer, Milwaukee, Wis. 
1942—Living Graduates, 92 
William M. Anderson, Richmond, Va. 
Ewald W. Busse, Denver, Colo. 
Frances M. Love, Richland, Wash. 
French H. McCain, Birmingham, Mich. 
C. Barber Mueller, St. Louis 
William G. Reese, Perry Point, Md. 
Herman Rice, Temple, Tex. 
Frank 0. Shobe, St. Louis 
George L Watkins, Farmington, Mo. 
Hiraku Ishida, Los Angeles, Calif. 
1941—Living Graduates, 93 
Robert J. Cook, St. Louis 
Jane Matthews Day, Montgomery, Ala. 
Charles E. Fildes, Poplar Bluff, Mo. 
B. W. Finkel, St. Louis 
Peter 0. Fleming, Topeka, Kan. 
Anne T. Goetsch, Berkeley, Calif. 
Samuel W. Gollub, St. Louis 
Leon Kahn, Beverly Hills, Calif. 
Geo. Bruce Lemmon, Springfield, Mo. 
Harold E. McCann, E. St. Louis 
V. A. Mueller, Wichita, Kan. 
C. A. Nielsen, Seattle, Wash. 
Joseph W. Noah, St. Louis 
Carol H. Rehm, Los Angeles, Calif. 
Allan M. Rossen, Los Angeles, Calif. 
William L. Topp, Seattle, Wash. 
Mitchell Yanow, Clayton, Mo. 
Cecil H. Blackburn, Selma, Ala. 
Bruce L. Canaga, Drexel Hill, Pa. 
Jane A. Erganian, Glen Rock, N. J. 
J. I. Moreland, Salem, Ore. 
Bernice A. Torin, St. Louis 
1940—Living Graduates, 92 
Robert R. Anschuetz, Alton, 111. 
Donald S. Bottom, Alton, 111. 
Seymour Brown, St. Louis 
Russell J. Crider, St. Charles, Mo. 
Roland R. Cross, Hines, 111. 
A. T. Esslinger, St. Louis 
L. R. Fernandez, Laupahoehoe, T. H. 
James M. Foerster, Wausau, Wis. 
Otto H. Grunow, St. Louis 
R. N. Hirst, Ogden, Utah 
Robert H. Johnson, Tulsa, Okla. 
Robert E. Koch, St. Louis 
James Mann, Boston, Mass. 
Gordon F. Moore, Alton, 111. 
Charles G. Obermeyer, St. Louis 
Willard D. Rowland, Portland, Ore. 
Llewellyn Sale, Jr., St. Louis 
John S. Skinner, St. Louis 
Robert M. Smith, St. Louis 
W. L. Tomlinson, St. Louis 
Leo A. Sachar, St. Louis 
Harry W. Sawyer, San Francisco, Calif. 
1939—Living Graduates, 96 
Alfred K. Baur, St. Louis 
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Irving L. Berger, Cleveland, Ohio 
Vilray P. Blair, Jr., St. Louis 
Leo J. Blum, Jr., Warner Robins, Ga. 
Joseph Borenstine, Kansas City, Mo. 
Sidney S. Boyers, W. New York, N. J. 
Mark J. Brockbank, Petaluma, Calif. 
Heinz E. Cron, San Francisco, Calif. 
William B. Hildebrand, Menasha, Wis. 
Leonard H. Jacobson, Miami Beach, Fla. 
Benjamin Milder, St. Louis 
Edward H. Reinhard, St Louis 
Minton D. Ritter, Margate City, N. J. 
R. J. Roscow, Evansville, Ind. 
Gerald A. Slusser, Silver City, N. Mex. 
O. W. Towers, St. Charles, Mo. 
John W. Dix, Miami, Fla. 
Leon J. Fox, St. Louis 
1938—Living Graduates, 92 
Harry A. Baers, North Hollywood, Calif. 
G. W. Blankenship, Anderson, Mo. 
Robert D. Brookes, St. Louis 
Margaret A. Carter, St. Louis 
Adolph H. Conrad, Jr., St. Louis 
Marion J. Dakin, Los Angeles, Calif. 
Lawrence M. Kotner, St. Louis 
Harry Mantz, Alton, 111. 
Robert G. Moles, Hanford, Calif. 
Anthony Piraino, Oberlin, Ohio 
Joseph H. Pollock, Los Angeles, Calif. 
Philip Rosenblatt, New York, N. Y. 
Samuel Schultz, Clayton, Mo. 
Roy W. Thomas, Redding, Calif. 
J. L. Doenges, Anderson, Ind. 
H. R. Gilbert, Wyandotte, Mich. 
Alexander A. Mueller, Los Angeles, 
Calif. 
1937—Living Graduates, 93 
Samuel Brady, Gary, Ind. 
Paul A. Brenner, Owensville, Mo. 
G. L. Calvy, Cleveland, Ohio 
R. G. Carter, Austin, Tex. 
Martin A. Compton, Richmond, Va. 
John R. Connell, Denver, Colo. 
Samuel M. Day, Jacksonville, Fla. 
J. M. Dougall, Houston, Tex. 
Thomas S. Boozer, Montgomery, Ala. 
Edward A. Harris, Birmingham, Ala. 
Lester E. Haentzschel, Appleton, Wis. 
A. E. Meisenbach, Jr., Dallas, Tex. 
John E. Miksicek, St. Louis 
H. L. Townsend, Louisville, Ky. 
Bernard C. Trowbridge, Kansas City, 
Mo. 
J. A. Fiorito, New Haven, Conn. 
William H. Gray, Yakima, Wash. 
Carroll W. Huffman, Los Angeles, Calif. 
Arthur A. Kaplan, Utica, N. Y. 
Robert C. Kingsland, St. Louis 
Carl E. Lischer, St. Louis 
Edgar H. Little, New Orleans, La. 
Lewis E. Littmann, St. Louis 
Elizabeth Lowenhaupt, San Francisco 
M. S. McGrath, Weiser, Idaho 
Ralph C. Petersen, Glendale, Calif. 
Charles M. Polan, Huntington, W. Va. 
William J. Quinn, Alturas, Calif. 
Henry N. Reid, Rome, N. Y. 
Lloyd Rosenbaum, Anderson, Ind. 
Harvey S. Smith, Boise, Idaho 
Walter Stevenson, Jr., Quincy, 111. 
H. L. Townsend, Louisville, Ky. 
David R. Wall, Wichita, Kan. 
Ellsworth A. Westrup, Webster Groves, 
Mo. 
Marie H. Wittier, Wheaton, 111. 
1936—Living Graduates, 102 
James H. Bryant, St. Louis 
F. R. Crouch, Farmington, Mo. 
Norman W. Drey, St. Louis 
Stephen Ellis, Coffeyville, Kan. 
Curtis H. Epps, Springfield, Mo. 
John L Horner, St. Louis 
W. H. Jacobson, Canton, Ohio 
Nathan R. Kahn, Brooklyn, N. Y. 
George M. Klingner, Springfield, Mo. 
Vernon Lundmark, Seattle, Wash. 
Frank McDowell, St. Louis 
James D. Morrison, Billings, Mont. 
R. A. Nussbaum, St. Louis 
Samuel Schneider, St. Louis 
William L Sellers, Jr., Mobile, Ala. 
E. H. Trowbridge, Jr., Kansas City, Mo. 
Michael S. Wepprich, Washington, Mo. 
Warren B. West, Ogden, Utah 
Robert A. Wise, Houston, Tex. 
Charles A. Brasher, Mt. Vernon, Mo. 
Lawrence Breslow, Chicago, 111. 
Hyman Jaffe, Beverly Hills, Calif. 
1935—Living Graduates, 88 
K. M. Amlin, Honolulu, T. H. 
: 
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I. J. Fiance, St. Louis 
Heinz Haffner, St. Louis 
Alfred W. Harris, Dallas, Tex. 
A. Herman Hutto, St. Louis 
Norman M. Johnson, Clarinda, Iowa 
Jacob Katzeff, Brooklyn, N. Y. 
Bruce Kenamore, St. Louis 
Kenneth V. Larsen, St. Louis 
Ellen S. Loeffel, St. Louis 
Edward Massie, St. Louis 
Sidney Messer, Venice, Calif. 
Clark G. Porter, Three Rivers, Mich. 
Laurence G. Pray, Fargo, N. D. 
David Rothman, St. Louis 
Bernard Schwartzman, St. Louis 
Ben H. Senturia, St. Louis 
A. J. Steiner, St. Louis 
David 0. Weiner, Brooklyn, N. Y. 
Irvin Weisman, Granite City, 111. 
Elmer G. Graul, St. Louis 
Arthur P. Echternacht, Fort Dodge, la. 
John W. Williams, Oak Grove, Mo. 
1934—Living Graduates, 88 
Helen M. Aff, St. Louis 
Edmund B. Alvis, St. Louis 
James M. Baker, Columbia, Mo. 
Garvey Bowers, Kokomo, Ind. 
Eugene M. Bricker, St. Louis 
L. F. Bush, Danville, Pa. 
Everett  S.  Caldemeyer,  Washington, 
D. C. 
T. C. Campbell, New Orleans, La. 
David Friedman, Granite City, 111. 
Ben I. Frissel,, Phoenix, Ariz. 
Paul O. Hagemann, St. Louis 
Stanley Hampton, St. Louis 
Louis G. Jekel, Phoenix, Ariz. 
Dorothy J. Jones, St. Louis 
Ralph R. Jones, Boise, Idaho 
Morris D. Marcus, St. Louis 
M. Norman Orgel, St. Louis 
H. D. Rosenbaum, St. Louis 
John A. Saxton, St. Louis 
Edna Schrick, Oakland, Calif. 
James G. Telfer, Chicago, 111. 
William W. Gist, Kansas City, Mo. 
Martin P. Hunter, Kansas City, Mo. 
Fred C. Reynolds, St. Louis 
1933—Living Graduates, 89 
Henry C. Allen, St. Louis 
James W. Bagby, St. Louis 
Russell J. Blattner, Houston, Tex. 
Cecil M. Charles, St. Louis 
Lee W. Dean, Jr., St. Louis 
Truman G. Drake, St. Louis 
Wallace D. English, Cardwell, Mo. 
Charles H. Flynn, Clarinda, la. 
George E. Grim, Kirksville, Mo. 
Carl G. Harford, St. Louis 
John R. Haslem, Terre Haute, Ind. 
W. W. Herman, Cleveland, Ohio 
Joseph C. Jaudon, St. Louis 
F. Craig Johnson, Denver, Colo. 
A. A. Loverde, Chicago, 111. 
R. R. Merrell, Pocatello, Idaho 
Alvin R. Miller, Seattle, Wash. 
Louis A. Motchan, Beverly Hills, Calif. 
Charles Oderr, New Orleans, La. 
Lyman K. Richardson, New Orleans, La. 
J. F. Roufa, St. Louis 
Richard Y. Sakimoto, Honolulu, T. H. 
Robert S. Smith, Boise, Idaho 
Robert T. Terry, Nashville, Tenn. 
Oreon K. Timm, Danville, 111. 
R. M. Van Matre, Oklahoma City, Okla. 
Wirt A. Warren, Wichita, Kan. 
Lawrence M. Wilson, Olympia, Wash. 
J. J. Wimp, Kirksville, Mo. 
Frank G. Zingale, St. Louis 
George E. Zukovich, San Diego, Calif. 
Lawrence M. Wilson, Olympia, Wash. 
George J. L. Wulff, Jr., St. Louis 
1932—Living Graduates, 85 
Harry Agress, St. Louis 
Sim F. Beam, St. Louis 
Brian B. Blades, Washington, D. C. 
Louis T. Byars, St. Louis 
B. S. Clark, Spearfish, S. D. 
William Ehrlich, Newark, N. J. 
Leo Gottlieb, St. Louis 
Kikoshi Inouye, Honolulu, T. H. 
D. H. Kaump, Detroit, Mich. 
Paul H. Lefkowitz, Spring Valley, N. Y. 
William H. Meinberg, St. Louis 
Carl V. Moore, St. Louis 
Paul B. Nutter, Spokane, Wash. 
Sydney S. Pearl, Elizabeth, N. J. 
C. O'Neil Rich, Salt Lake City, Utah 
Wendell G. Scott, St. Louis 
Don J. Silsby, Springfield, Mo. 
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Barrett L. Taussig, St. Louis 
Dwight H. Trowbridge, Fresno, Calif. 
Sam R. Wallis, Kauai, T. H. 
Helman C. Wasserman, St. Louis 
John C. Wilson, San Jose, Calif. 
Irving Wyle, Brooklyn, N. Y. 
Virgil E. Jeans, Joplin, Mo. 
Donald M. Paton, Houston, Tex. 
1931—Living Graduates, 73 
Delevan Calkins, St. Louis 
E. W. Cannady, E. St. Louis, 111. 
Joseph Cieri, Piedmont, Calif. 
D. B. Elrod, Cape Girardeau, Mo. 
A. W. Hankwitz, Milwaukee, Wis. 
W. E. Keiter, Kinston, N. C. 
Morris Krutchkoff, San Francisco, Calif. 
Mary Louise Newman, Jacksonville, 111. 
Max Magnes, Paterson, N. J. 
H. R. McCarroll, St. Louis 
Robert F. Monroe, Louisville, Ky. 
Ben Friedman, McKinney, Tex. 
W. Wallace Green, Kansas City, Mo. 
Edwin C. Schmidtke, Columbia, Mo. 
John A. Schindler, Monroe, Wis. 
R. B. Wray, Nevada, Mo. 
1930—Living Graduates, 76 
Harold S. Bowman, Wichita, Kan. 
M. A. Brennecke, Waimea, Kauai, T. H. 
J. Paul Burgess, Hyrum, Utah 
M. A. Diehr, St. Louis 
Donald E. Eggleston, Macon, Mo. 
Virgin 0. Fish, St. Louis 
Herbert H. Gass, India 
Joseph J. Gitt, St. Louis 
Stanley Harrison, St. Louis 
Alfred H. Hathcock, Fayetteville, Ark. 
Walter M. Howard, Joplin, Mo. 
James D. Horton, Springfield, Mo. 
I. D. Newmark, Chester, 111. 
1929—Living Graduates, 71 
Carl S. Bickel, Wheeling, W. Va. 
Leslie C. Drews, Clayton, Mo. 
A. W. Freshman, Denver, Colo. 
Guerdan Hardy, St. Louis 
Craig B. Johnston, Philadelphia, Pa. 
Louis Kovitz, Kansas City, Mo. 
Sidney Pakula, Kansas City, Mo. 
Frank B. Queen, Portland, Ore. 
A. P. Rowlette, Moberly, Mo. 
Jay Marvin Salzman, Springfield, 111. 
A. Ford Wolf, Temple, Tex. 
Grace Edwards Barar, Allahabad, India 
F. L. Harms, Salisbury, Mo. 
V. L. Peterson, Charleston, W. Va. 
Arthur E. Varden, San Bernardino, 
Calif. 
1928—Living Graduates, 69 
A. N. Arneson, St. Louis 
William Brewer, Hays, Kans. 
Edward Burns, Toledo, Ohio 
Justin J. Cordonnier, St. Louis 
Roland F. Elkins, Springfield, Mo. 
John S. Harter, Louisville, Ky. 
H. R. Hildreth, St. Louis 
Laurence L. Howard, Great Falls, Mont. 
J. Ted Jean, St. Louis 
R. D. Kepner, Honolulu, T. H. 
Guy N. Magness, St. Louis 
L. A. Malone, Terre Haute, Ind. 
Earl L. Mills, Wichita, Kan. 
John F. Patton, St. Louis 
A. Victor Reese, St. Louis 
Paul R. Rollins, Seattle, Wash. 
Verne Ross, Stockton, Calif. 
W. A. Ruch, Memphis, Tenn. 
0. G. Schneidewind, New Athens, 111. 
B. Wright Shelton, Miami Okla., 
David M. Skilling, St. Louis 
A. Lloyd Stockwell, Kansas City, Mo. 
Jacob Stolar, St. Louis 
Vincent T. Williams, Kansas City, Mo. 
George H. Wood, Carthage, Mo. 
1927—Living Graduates, 70 
Everett C. Drash, Charlottesville, Va. 
A. C. Fortney, Fargo, N. D. 
Paul H. Guttman, Sacramento, Calif. 
Alfred G. Henrich, Los Angeles, Calif. 
Irene A. Koeneke, Halstead, Kans. 
C. H. Leslie, Kirkwood, Mo. 
W. R. Merrell, Brigham City, Utah 
Alfred J. Metscher, Enid, Okla. 
Kazuo Miyamoto, Honolulu, T. H. 
Eugene O. Parsons, Kansas City, Mo. 
Willard C. Schwartz, Manhattan, Kan. 
Abigail E. Smith, Lexington, Mass. 
Frances H. Stewart, St. Louis 
Richard T. Taylor, Los Angeles, Calif. 
Louis L. Tureen, St. Louis 
Franklin Walton, St. Louis 
W. B. Wilcoxen, Bowling Green, Mo. 
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George S. Wilson, Enid, Okla. 
Louis F. Aitken, St. Louis 
A. G. Klein, St. Louis 
1926—Living Graduates, 73 
Reno A. Ahlvin, Kankakee, 111. 
Herbert Anderson, Los Angeles, Calif. 
Willard Bartlett, Jr., St. Louis 
James L. Benepe, St. Paul, Minn. 
H. M. Chandler, Waipahu, T. H. 
Erich A. Cunningham, Louisiana, Mo. 
Max Deutch, St. Louis 
Andy Hall, Jr., St. Louis 
William M. James, St. Louis 
William B. Kountz, St. Louis 
John G. Manning, McMinnville, Ore. 
G. Wendell Olson, Fullerton, Calif. 
Walter R. Peterson, Trenton, N. J. 
Bernard Rand, New York City 
Henry A. Romberg, Oshkosh, Wis. 
J. C. Schmidtke, Elgin, 111. 
E. H. Theis, Granite City, 111. 
Charles W. Duden, St. Louis 
1925—Living Graduates, 67 
George P. Bailey, Lakewood, Colo. 
Robert J. Crossen, St. Louis 
H. M. Denny, Union, Mo. 
James J. Donohue, E. St. Louis, 111. 
B. Y. Glassberg, St. Louis 
A. E. Hiebert, Wichita, Kan. 
Richard K. Kimmel, St. Louis 
James I. Knott, San Diego, Calif. 
S. D. Soule, St. Louis 
Jerome S. Levy, Little Rock, Ark. 
Joseph Magidson, St. Louis 
Carl H. Matthey, Davenport, Iowa 
Loren D. Moore, Wellesley Hills, Mass. 
Sam. J. Roberts, Miami, Fla. 
Melvin A. Roblee, St. Louis 
Roland A. Slater, Peoria, 111. 
Winton T. Stacy, Fort Sill, Okla. 
R. 0. Stickler, Kirksville, Mo. 
Gershom J. Thomson, Rochester, Minn. 
Hugo O. Wagner, Great Lakes, 111. 
James O. Nail, Marion, Ky. 
1924—Living Graduates,  68 
Alfred O. Adams, Spokane, Wash. 
Roy F. Baskett, Texarkana, Tex. 
J. William Beckmann, New York, N. Y. 
Harry J. Davis, Topeka, Kans. 
Charles Drabkin, Los Angeles, Calif. 
Perry E. Duncan, Springfield, 111. 
George H. Garrison, Oklahoma City, 
Okla. 
H. V. Gibson, Great Falls, Mont. 
William B. Gnagi, Monroe, Wis. 
Scott Johnson, New York City 
Louis H. Jorstad, St. Louis 
Elizabeth E. Koppenaal, Elmhurst, 111. 
A. E. Meinert, Winona, Minn. 
E. B. Pfefferkorn, Oshkosh, Wis. 
Reuben M. Smith, St. Louis 
0. Earl Whitsell, St. Joseph, Mo. 
Eugene S. Auer, Denver, Colo. 
1923—Living Graduates, 47 
Oliver Abel, Jr., St. Louis 
William G. Becke, St. Louis 
William L. Bradford, Rochester, N. Y. 
James Barrett Brown, St. Louis 
Ben M. Bull, Ironton, Mo. 
1. Z. Davidoff, Milwaukee, Wis. 
Walter J. Decker, Westfield, Pa. 
George V. Feist, Kansas City, Mo. 
Ben  D.  Senturia, Chicago, 111. 
Charles Teel, Bellingham, Wash. 
J. Wm. Thompson, St. Louis 
Clair 0. Vingom, Madison, Wis. 
Elias H. Schlomovitz, Milwaukee, Wis. 
1922—Living Graduates, 44 
K. S. Chouke, Philadelphia, Pa. 
Calvin Clay, St. Charles, Mo. 
James B. Costen, St. Louis 
Aphrodite J. Hofsommer, Webster 
Groves, Mo. 
Armin C. Hofsommer, Webster Groves, 
Mo. 
Kirby A. Martin, New York, N. Y. 
F. E. Sultzman, Hannibal, Mo. 
1921—Living Graduates, 42 
Lester J. Evans, Jackson Heights, N. Y. 
J. C. McKitterick, Burlington, Iowa 
Harvey S. Rusk, Pueblo, Colo. 
Oscar C. Zink, St. Louis 
1920—Living Graduates, 39 
Robert L. Andrae, Louisiana, Mo. 
Clifton H. Briggs, Pasadena, Calif. 
Warren H. Cole, Chicago, 111. 
Alfred Goldman, St. Louis 
Samuel B. Grant, St. Louis 
Guy H. Hopkins, Pueblo, Colo. 
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William A. Hudson, Detroit, Mich. 
W. N. Jenkins, Port Gibson, Miss. 
Frederick E. Jostes, St. Louis 
P. H. Kennedy, Hubbard, Ohio 
Herman M. Meyer, St. Louis 
L. J. Owen, Lincoln, Neb. 
M. G. Peterman, Milwaukee, Wis. 
Royal W. Rudolph, Tucson, Ariz. 
H. W. Wellmerling, Bloomington, 111. 
Harvey Lester White, St. Louis 
1919—Living Graduates, 45 
Duff S. Allen, St. Louis 
S. P. Funkhouser, Lake County, Calif. 
Howard H. Heuston, Bolder, Colo. 
Fred J. Hodges, Ann Arbor, Mich. 
Carl 0. Kohlbry, Duluth, Minn. 
Marriott T. Morrison, Mt. Horeb, Wis. 
E. H. Munro, Grand Junction, Colo. 
Raymond L Murdoch, Oklahoma City, 
Okla. 
Howard A. Plank, New York, N. Y. 
A. B. Raffl, Syracuse, N. Y. 
R. P. Roantree, Elko, Nev. 
A. L Walter, Sedalia, Mo. 
1918—Living Graduates, 26 
Glover H. Copher, St. Louis 
Wilbur G. Gillett, Wichita, Kan. 
Elmer N. Liljedahl, Hollywood, Calif. 
Arthur G. Mahle, Chicago, 111. 
J. F. Pessel, Trenton, N. J. 
O. Sundwall, Murray, Utah 
James A. Tesson, Kansas City, Mo. 
1917—Living Graduates, 25 
Archie A. Skemp, La Crosse, Wis. 
J. E. Wattenberg, Cortland, N. Y. 
1916—Living Graduates, 13 
E. L. Dallwig, Milwaukee, Wis. 
Earl C. Sage, Omaha, Neb. 
Ray T. Woolsey, Salt Lake City, Utah 
1915—Living Graduates, 20 
D. K. Rose, St. Louis 
J. E. Strode, Honolulu, T. H. 
W. T. Wilkening, Fort Scott, Kans. 
1914—Living Graduates, 8 
O. F. McKittrick, Linglestown, Pa. 
John T. McLarney, Brookfleld, Mo. 
1913—Living Graduates, 20 
F. 0.   Kettelkamp,   Colorado   Springs, 
Colo. 
1912—Living Graduates, 30 
C. F. DeGaris, Oklahoma City, Okla. 
Roy G. Empson, Valmeyer, 111. 
Edwin C. Ernst, St. Louis 
George S. Gilpin, Cleveland, O. 
W. N. O'Bannon, New Madrid, Mo. 
Wells C. Reid, Goodrich, Mich. 
A. P. Erich Schulz, St. Charles, Mo. 
George L. Watkins, Farmington, Mo. 
1911—Living Graduates, 20 
Thomas M. Davis, St. Louis 
Clyde P. Dyer, St. Louis 
William H. Fickel, Denver, Colo. 
Charles H. Hecker, Palo Alto, Calif. 
Arthur J. Wagers, Philadelphia, Pa. 
1910—Living Graduates, 40 
Stanley S. Burns, St. Louis 
Frederic Hagler, Springfield, Mass. 
Robert M. Hardaway, Wheatridge, Colo. 
John P. Keim, St. Louis 
Peter G. Moskop, St. Louis 
Claude D. Pickrell, St. Louis 
Frederick O. Schwartz, St. Louis 
1909—Living Graduates, 29 
James W. Barrow, Carbondale, 111. 
Carey B. Elliott, Raton, N. Mex. 
W. N. Pugh, Salt Lake City, Utah 
Richard S. Weiss, St. Louis 
1908—Living Graduates, 29 
W. A. Olds, Colville, Wash. 
O. J. Raeder, Boston, Mass. 
W. D. Moore, San Pedro, Calif. 
1907—Living Graduates, 28 
C. C. Nash, Dallas, Tex. 
Grandison D. Royston, Hope, Ark. 
Llewellyn Sale, St. Louis 
Raymond M. Spivy, St. Louis 
1906—Living Graduates, 33 
Martin J. Glaser, St. Louis 
Arthur Gundlach, St. Louis 
T. A. Lawler, Taylorville, 111. 
S. P. Martin, East Pairie, Mo. 
S. B. McPheeters, Goldsboro, N. C. 
William H. Smith, Colfax, Calif. 
1905—Living Graduates, 30 
Jerome E. Cook, St. Louis 
Walter Fischel, St. Louis 
Harry M. Griffith, Pasadena, Calif. 
J. M. James, Henning, 111. 
O. W. Knewitz, East St. Louis 
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1904—Living Graduates, 31 
Paul Baldwin, Kennett, Mo. 
W. Q. Conway, Kalispell, Mont. 
N. M. Freund, St. Louis 
Harry L. Jones, Kansas City, Mo. 
Roy P. Scholz, St. Louis 
J. H. Woodridge, Pueblo, Colo. 
1903—Living Graduates, 20 
A. H. Myerdick, Mt. Pleasant, Iowa 
Clive D. Scott, Louisiana, Mo. 
1902—Living Graduates, 22 
1901—Living Graduates, 14 
John M. Bradley, St. Louis 
W. C. Forder, St. Louis 
Walter C. G. Kirchner, St. Louis 
M. K. Wyler, Albuquerque, N. Mex. 
1900—Living Graduates, 2 
1899—Living Graduates, 34 
J. C. Caldwell, Wellington, Kans. 
C. L. Lawless, Marshall, Mo. 
R. O. Raymond, Flagstaff, Ariz. 
>elden Spencer, St. Louis 
Julian B. Woodson, Lowesville, Va. 
1898—Living Graduates, 27 
J. G. W. Fischer, Alma, Mo. 
R. B. H. Gradwphl, St. Louis 
John Q. Roane, Carlyle, 111. 
A. L. Stuttle, Williamsville, 111. 
1897—Living Graduates, 21 
Theodore Greiner, St. Louis 
Frederick E. Woodruff, St. Louis 
1896—Living Graduates, 21 
1895—Living Graduates, 21 
H. A. Geitz, Monterrey, N. L., Mexico 
Sandor Horwitz, Peoria, 111. 
Robert J. Terry, St. Louis 
William A. Tolleson, Eufala, Okla. 
1894—Living Graduates, 13 
1893—Living Graduates, 12 
Andrew Darling, St. Louis 
R. Clarence Stephens, Plymouth, Ind. 
1892—Living Graduates, 4 
1891—Living Graduates, 15 
1890'—Living Graduates, 6 
1889—Living Graduates, 6 
1888—Living Graduates, 2 
1887—Living Graduates, 3 
1886—Living Graduates, 3 
1885—Living Graduates, 2 
E. F. Ellis, Fayetteville, Ark. 
1884—Living Graduates, 2 
1883—Living Graduates, 2 
W. A. Fries, St. Louis 
1882—Living Graduates, 1 
1881—Living Graduates, 3 
James A. Dickson, St. Louis 
Willis Hall, St. Louis 
1880—Living Graduates, 2 
OTHER DONORS 
Mrs. T. R. Akin, Clayton, Mo. 
Mr. William M. Akin, St. Louis 
Harry L. Alexander, M.D., St. Louis 
Robert W. Bartlett, M.D., St. Louis 
Leon Bromberg, M.D., St. Louis 
J. J. Bronfenbrenner, Ph.D., St. Louis 
Samuel S. Bukantz, M.D., St. Louis 
Martin M. Calodney, M.D., St. Louis 
Benjamin H. Charles, M.D., St. Louis 
Drs. Carl F. and Gerty T. Cori, St. Louis 
Gustave J. Dammin, M.D., St. Louis 
Morris Davidson, M.D., St. Louis 
Hallowell Davis, M.D., St. Louis 
Joseph E. Edwards, M.D., St. Louis 
Ben Eiseman, M.D., St. Louis 
Robert Elman, M.D., St. Louis 
Lee T. Ford, St. Louis 
Robert J. Glaser, M.D., St. Louis 
Harry N. Glick, M.D., St. Louis 
Drs. Evarts and Helen Tredway Graham, 
St. Louis 
G. E. Gruenfeld, M.D., St. Louis 
Miss Helen D. Harkness, St. Louis 
Leopold Hofstatter, M.D., St. Louis 
Mr. W. W. Horner, St. Louis 
Alex H. Kaplan, M.D., St. Louis 
J. Albert Key, St. Louis 
John Esben Kirk, M.D., St. Louis 
Paul E. Kubitschek, M.D., St. Louis 
K. Cramer, Lewis, St. Louis 
Grover Liese, M.D., St. Louis 
Robert G. Loeffel, St. Louis 
Sedgwick Mead., M.D., St. Louis 
Albert I. Mendeloff, M.D., St. Louis 
Ivan N. Mensh, Ph.D., St. Louis 
William H. Olmsted, M.D., St. Louis 
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Ernest H. Parsons, M.D., St. Louis 
Joseph C. Peden, Sr., M.D., St. Louis 
Lawrence T. Post, M.D., St. Louis 
M. Hayward Post, M.D., St. Louis 
Herman J. Rosenfeld, M.D., St. Louis 
Theodore B. Rosenthal, Ph.D., St. Louis 
Harold Scheff, M.D., St. Louis 
Arthur E. Strauss, M.D., St. Louis 
A. C. Stutsman, M.D., St. Louis 
Robert Votaw, M.D., St. Louis 
Theodore Walsh, M.D., St. Louis 
Carl R. Wegner, M.D., St. Louis 
Park J. White, M.D., St. Louis 
Ralph B. Woolf, M.D., St. Louis 
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DEPARTMENTAL   NEWS 
Anatomy 
Dr. Edward W. Dempsey, professor 
of anatomy, attended a meeting spon- 
sored by the Ciba Foundation in Lon- 
don, England, April 9-12. He presented 
a paper on "The Experimental Induc- 
tion of Sexual Behavior by Steroid Hor- 
mones," during this conference on the 
influence of steroid hormones on psy- 
chological   and  behaviourial  reactions. 
The keynote address of the Confer- 
ence on Aging sponsored by Smith, 
Kline and French Laboratories in Phil- 
adelphia on Feb. 15 was given by Dr. 
Edmund V. Cowdry, research professor 
of anatomy. He spoke on "The Im- 
portance of Research on Aging in the 
National Emergency." 
An exhibit entitled "The Separate 
Neural Arch—A Study of the Incidence 
from the Fetus to Maturity," was 
awarded the silver medal for second 
place and a certificate of merit at the 
American Academy of Orthopedic Sur- 
geons meeting in Chicago, Jan. 27 to 
Feb. 1. Dr. Maurice B. Roche, instruc- 
tor in clinical orthopedic surgery, pre- 
sented the exhibit, which was prepared 
by him and Dr. George G. Rowe, former 
instructor in anatomy. They presented 
a selected series of some 36 lumbo- 
sacral columns from the Terry Anatom- 
ical Collection. 
First prize in the exhibits at the 
meeting went to Dr. T. J. Stewart, cur- 
ator of physical anthropology at the 
Smithsonian Institute in Washington, 
and former staff member of the Medi- 
cal School. Dr. Stewart was visiting 
professor of anatomy during 1943. 
Internal Medicine 
Dr. Harry A. Schroeder, associate 
professor of medicine, delivered the an- 
nual Alpha Omega Alpha lecture at 
McGill University, Montreal, Canada, 
on March 1, speaking on "Congestive 
Failure." He spoke at the initiation 
dinner. While in Montreal, he also ad- 
dressed the Montreal Medico-Chirurgi- 
cal Society, March 2, on "The Patho- 
genesis of Hypertension." 
On Feb. 1-3, Dr. Schroeder addressed 
the Recess Commission on Hyperten- 
sion of the Commonwealth of Massa- 
chusetts in Boston on "The Evidence 
That Essential Hypertension Is Not a 
Single Disease Entity," and led the dis- 
cussion which followed. 
The United States Public Health Ser- 
vice has renewed a grant to Dr. Harry 
L. Alexander, professor of clinical med- 
icine, for continuation of research on 
the metabolism of lipid antigens by Dr. 
Samuel Bukantz on a joint project with 
Drs. Gustave Dammin and Frank J. 
Dixon. 
Dr. Alexander is chairman of a com- 
mittee appointed by the American Acad- 
emy of Allergy, at the requests of the 
surgeon general of the army, navy, air 
force and Public Health Service, to re- 
view standards for the induction of men 
suffering from allergic disorders into 
the service. Dr. Stanley Hampton is a 
member of the committee. 
Dr. Samuel C. Bukantz, assistant pro- 
fessor of medicine, has been appointed 
chairman of the committee on clinical 
investigation on food allergy of the 
Research  Council,  American  Academy 
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of Allergy. The committee is in organi- 
zation and drawing up plans for investi- 
gative work. 
•< A reseach grant of $7350 has been 
awarded to the School of Medicine for 
work in heart disease by the Life Insur- 
ance Medical Research Fund. 
The grant is for research by Dr. Rob- 
ert J. Glaser, assistant professor of med- 
icine, for work on the pathogenesis of 
experimental streptococcal infections 
and their relation to rheumatic fever. 
Other fellowships have been awarded to 
Dr. Joseph Larner, fellow in biological 
chemistry, and Dr. H. Mitchell Perry, 
research fellow in medicine. 
Neuropsychiatry 
Dr. Edwin F. Gildea, professor of 
psychiatry, will address the third an- 
nual neuropsychiatric meeting held at 
North Little Rock Veterans Administra- 
tion Hospital, March 1 and 2. His topic 
is "Research in Psychiatry, Particularly 
as Exemplified by the Milbank Founda- 
tion Symposium on Biological Aspects 
of Mental Health and Disease." 
Otolaryngology 
Dr. Theodore E. Walsh was guest 
speaker at several sessions of the 
postgraduate course sponsored by the 
Oregon Academy of Ophthalmology 
and Otolaryngology. He presented six 
papers for the course. On Feb. 27, Dr. 
Walsh was guest speaker for the teach- 
ing day session of the Otolaryngology 
Department at Syracuse University 
Medical College in New York. 
Dr. Hallowell Davis, director of re- 
search at Central Institute for the Deaf 
and research professor of otolaryngol- 
ogy, left Feb. 5 for an extensive lecture 
and inspection tour through Europe un- 
der auspices of the Office of Naval Re- 
search. 
Officially classified as a navel techni- 
cian on the trip, Dr. Davis visited labo- 
ratories and gave lectures in France, 
Switzerland, Sweden, Denmark, Hol- 
land, Belgium and England. Purpose 
of this tour was to exchange informa- 
tion with scientists in the democratic 
countries of Europe on research prob- 
lems about neurophysiology of the ear. 
In Sweden, Dr. Davis delivered a 
series of three lectures describing re- 
search work at Central Institute. He 
spoke before the Karolinska Institutet 
of Stockholm and the medical faculties 
of the Universities of Upsala and Lund, 
and gave informal lectures in Switzer- 
land, England and Holland. 
Dr. Davis is in charge of special 
naval research projects being conducted 
at C.I.D., and is chairman of the Com- 
mittee on Hearing of the National Re- 
search Council. He is also part-time 
professor of physiology on the Medical 
School staff. 
Pathology 
During the week of April 8, Dr. Rob- 
ert A. Moore, Dean and professor of 
pathology, was at the University of 
Pennsylvania in Philadelphia to take 
part in meetings of the committee on 
the survey of medical education, a 
group formed jointly by the American 
Medical Association and the Association 
of American Medical Colleges, which 
recently completed an extensive survey 
of medical schools in this country. 
Dr. Frank J. Dixon, Jr., assistant pro- 
■■■■■'■ 







fessor of pathology, has resigned to 
accept the position of professor of 
pathology at the University of Pitts- 
burgh, Pa., on May 1. A graduate of 
the University of Minnesota in 1943, he 
has been on the Washington University 
staff since the summer of 1948, when 
he came here as an instructor in pathol- 
ogy. Dr. Dixon served with the Navy 
during World War II and attained the 
rank of lieutenant. 
Dr. David W. Talmage of the Depart- 
ment of Medicine, also will leave the 
staff to accept a position as assistant re- 
search professor in the department of 
pathology at the University of Pitts- 
burgh. His appointment is also effective 
on May 1. 
Preventive Medicine 
Dr. Robert E. Shank, '39, professor 
of preventive medicine and public 
health, spoke at the meeting of the Food 
Industries Advisory Council of the Nu- 
trition Foundation at Skytop Lodge, 
Pa., on April 25. 
Radiology 
Dr. Hugh M. Wilson, '27, professor 
of radiology, was elected president of 
the St. Louis Society of Radiologists at 
a recent meeting. 
Dr. Wendell G. Scott, '32, associate 
professor of clinical radiology, gave 
two papers before the Post-Graduate 
Medical Study Course in Radiology at 
the University of Kansas Medical Cen- 
ter, Kansas City, Kansas, on January 9. 
He spoke on "Developments in Cerebral 
Angiography" and "Technical and Clin- 
ical   Use   of   Cardiovascular   Angiog- 
raphy." 
Surgery 
The Henry Jacob Bigelow Medal of 
the Boston Surgical Society was 
awarded to Dr. Evarts A. Graham, 
Bixby professor of surgery, during a 
meeting of the Society in Boston on 
April 20. On March 15, Dr. Graham 
addressed the fifth annual Michigan 
Postgraduate Clinical Institute on 
"Common Errors in the Diagnosis of 
Bronchiogenic Carcinoma." 
At the annual meeting of the Society 
of University Surgeons, held this year 
at Durham, N. C, from Feb. 8 to 10, 
Dr. Eugene M. Bricker, '34, associate 
professor of clinical surgery, was 
chosen president-elect of the Society for 
the year 1952. He presented a paper 
on "The Role of Pelvic Evisceration in 
Surgery," during the meeting. 
Drs. Henry G. Schwartz, George E. 
Roulhac, and Leonard T. Furlow at- 
tended the meeting of the Southern 
Neurosurgical Society in New Orleans 
on Feb. 9 and 10. Dr. Schwartz is 
secretary of the Society. 
Gerontology 
Participating in a panel discussion 
on "Better Health for Older People" on 
Feb. 27, were Dr. William B. Kontz, 
Dr. John Esben Kirk, Dr. Margaret 
Chieffi of the Division of Gerontology, 
and Dr. Sedgwick Mead, assistant pro- 
fessor of physical medicine. The topic 
of forced retirement of employees at 
an arbitrary age was discussed before 
a meeting of the St. Louis Academy of 
General Practice. 
ALUMNI   NEWS 
1883 
William A. Fries, one of the oldest 
practicing physicians in St. Louis, cele- 
brated his 90th birthday on January 12 
by making his regular rounds of patients. 
His office now is at his home, 3209 Shen- 
andoah Avenue, but for 66 years, until a 
year ago, he had his office at 1544 S. 
Broadway. The only reason he moved 
then was that the roof was blown off in a 
storm. Dr. Pries lives a quiet life fol- 
lowing regular habits and getting exer- 
cise by ignoring elevators in hospitals 
and using the stairs. 
1893 
Arthur R. Stover has changed his ad- 
dress from Kingman, Ariz., to Box 96, 
Holbrook, Ariz. He writes that he views 
with pleasure the progress being made 
by the School of Medicine. 
1895 
Forty "old timers" of the School of 
Medicine and the University gave a party 
in honor of Robert J. Terry's 80th birth- 
day on January 25. The group included 
maintenance men and secretaries from 
the School of Medicine, as well as pro- 
fessional staff members and friends. A 
birthday cake with 80 candles and a spe- 
cial copy of the Medical Alumni Quarterly 
for January, which was autographed by 
all those present, were given to Dr. 
Terry. Among those attending the party 
were: Dr. Robert Schlueter '95, Dr. Bor- 
den S. Veeder, Dr. Philip Shaffer, Dr. 
Joseph Erlanger, Dr. Sherwood Moore, 
'05, Dr. E. V. Cowdry, Dr. Robert A. 
Moore, Dr. Mildred Trotter, Miss Agnes 
O'Gorman, Mr. Erik Carlson, Mr. Paul 
Bauer, Mr. Albert Gigi, and many asso- 
ciates from the Department of Anatomy. 
1905 
Robert A. (Dr. Bob) Schlernitzauer has 
been retired from practice for several 
years and is now in the private order 
fruit business with his son at Cocoa, Fla., 
in the Indian River fruit country. 
1905 
R. Manton Wilson sends word that he 
is now health officer for Henrico County, 
Virginia, and celebrated his 71st birthday 
in January. Prom 1908 until 1947, Dr. 
Wilson was a medical missionary in 
Korea, where he worked with lepers and 
established a large colony near Soonchun 
which was named after him. Returning 
to this country when the second World 
War began in 1941, he was health officer 
for the city of Richmond, Va., from then 
until 1946, when he went back to Korea. 
He was advisor on leprosy to the U. S. 
Army in Korea and directed a program 
of gathering lepers and establishing a 
colony in an old Japanese fort near 
Pusan. This latter colony now has 1200 
cases of Hansen's disease and is being 
supplied with food by the V. S. Army. 
He has had word that the R. M. Wilson 
colony recently fell into the hands of 
the Communists and the patients there 
have been mistreated and scattered. Dr. 
Wilson came back to this country and 
since December, 1948, has been in Hen- 
rico County. He has five sons, four of 
whom are M.D.'s, and two daughters. 
1911 
J. C. Drake, who practiced medicine at 
Kerman, Calif., for 30 years before re- 
tiring in August, 1948, has accepted a 
position as assistant county health officer 
of Fresno County "for the duration." He 
conducts 15 child health clinics each 
month, three in the city of Fresno and 
12 in the county. He now lives at 134 
W. McKinley Ave., Fresno. 
1917 
Robert Mueller has been named chair- 
man of the Missouri Advisory Committee 
on the Selection of Doctors, Dentists and 
Allied Specialists under the Selective 
Service Act. Dr. Mueller served as head 
of the Physicians' Procurement and As- 
signment Service in Missouri during 
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to apportion Missouri physicians, dentists 
and allied specialists properly between 
the civilian population and the armed 
forces. 
1923 
K. W. Steubner recently moved his 
office to 35 N. Central Ave., in Clayton, 
Mo. 
Elmer 0. Breckenridge can be reached 
in care of general delivery at Mason, 
Texas. 
1928 
Col. Earl Maxwell recently was named 
Acting Director of Professional Services, 
Office of the Surgeon General, U. S. Air 
Force, in Washington, D. C. Col. Max- 
well was Theater Surgeon in the South 
Pacific from July 1942 to 1944, and for 
the following nine months was Task 
Force Surgeon for the Okinawa cam- 
paign in World War II. After a period of 
occupation duty in Japan, he was staff 
member at Letterman Army Hospital 
from June, 1946, until he took over his 
present assignment. He was chief of 
ENT service, has been certified by the 
American Board of Ophthalmology, and 
accept^d by the American Academy of 
Ophthalmology and Otolaryngology. 
Wilford F. Hall has been promoted to 
to the rank of brigadier general, and 
now is air surgeon for the Military Air 
Transport Service. His specialty is 
E.N.T., and he has studied extensively on 
aerotitis. Dr. and Mrs. Hall have two 
children, Ronald Dexter, five, and Carol 
Lynne, one year old. They live at 1213 
N. Evergreen St., Arlington, Va. 
Paul I. Kobinson has been promoted to 
the rank of brigadier general, and his 
new title is Chief of Army Medical and 
Civilian Personnel. His duties include 
procurement and placement of medical 
personnel; doctors, nurses, dentists, and 
medical specialists. The largest division 
in the Medical Corps also is under Gen. 
Robinson. In addition to his work at the 
Surgeon General's office in Washington, 
Gen. Robinson is on the Medical School 
staff and teaches eight hours of hospital 
administration each year. 
1929 
Craig B. Johnson has moved from the 
U.  S. Naval Hospital in Philadelphia to 
the Naval Hospital at Bainbridge, Mary- 
land, effective March 10. 
1931 
Ben Friedman is at the Veterans Hos- 
pital in McKinney, Tex. 
1932 
Paul Lefkowitz lives in Spring Valley, 
N. Y., and his address is 25 S. Main St. 
1934 
Jane E. Frisch now lives at 5736 Mc- 
Pherson Ave., in St. Louis. 
Charles E. Stindel has moved recently 
to 341 Violet Ave., in Webster Groves, Mo. 
1935 
Walter K. Langston has offices in the 
Professional Bldg.,  Springfield, Mo. 
Arthur P. Echternacht has an address 
at 728 Crest Ave., Fort Dodge, Iowa. 
John W. Williams is living and prac- 
ticing in Oak Grove, Mo. 
1937 
The address of Lester E. Haentzschel 
is  228  W.  College  Ave.,  Appleton,  Wis- 
COnsln
- 1938 
Kenneth L. Carter is in Beloit, Wis- 
consin, where he is associated with the 
Beloit Clinic as surgeon. 
Joe Parker is now located at 2516 N. 
Hudson, Oklahoma City, Okla. 
Robert K. Robinson, Jr., is engaged in 
the private practice of maxillo-facial and 
plastic surgery in the Brockbank Profes- 
sional Bldg., in Salt Lake City at 141 E. 
2nd South St., and reports that he likes 
Salt Lake City very much. He and Mrs. 
Robinson have four sons. 
Winfield S. Wilder is director of Mon- 
tana's Mental Hygiene Clinics, with of- 
fices at Great Falls and at Butte. His 
address is 1401 Second Avenue, North, 
in Great Falls. He writes that he fre- 
quently saw Cornelius Meeker, '38, who 
was practicing pediatrics in Butte, before 
Dr. Meeker left for navy duty in July, 
1950. 
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1939 
Raymond F. Kuhlmann is living at 21 
Elson Parkway, South Burlington, Ver- 
mont. He is a member of the Crippled 
Children's Division of the Vermont De- 
partment of Health. 
1910 
Mary E. Bowen has a new address at 
7449 Cottage Grove Ave., in Chicago, Illi- 
nois. Her practice is limited to obstet- 
rics-gynecology. 
James H. Robertson recently announced 
the opening of his new offices at 1405 San 
Marino Ave., in San Marino, California. 
He is a diplomate of the American Board 
of Otolaryngology, and limits his practice 
to ear, nose and throat. 
1911 
The office of D. Cramer Reed is located 
in the First National Bank Building in 
Wichita, Kansas. 
Cecil H. Blackburn's office is in the 
Swift Building, Selma, Alabama. 
Henry Schwarz is on the staff of the 
Veterans Administration Hospital in As- 
pinwall, Pa. 
Mitchell Yanow recently moved his of- 
fice to 35 N. Central Ave., in Clayton, Mo. 
1912 
Hiraku Ishida is practicing in Los 
Angeles, with his office at 2630 W. Jeffer- 
son Blvd. 
James R. Herz has moved from Kansas 
City to 508 Humboldt, Reno, Nev. 
Sven L. Melsraard now lives at 6831 
Cherry St., in Kansas City, Mo. 
Glenn 0. Turner is now located at 920 
E. Elm St., in Springfield, Mo. 
Walter P. Granl has moved from Phila- 
delphia to St. Louis, where his office is 
in the Beaumont Medical Building, 3720 
Washington. 
Bill Reese writes the following: "Dear 
Alumni (particularly of '42): I recently 
assumed the duties of professor and head 
of the department of neuropsychiatry at 
the School of Medicine of the University 
of Arkansas, Little Rock, Ark. The clin- 
ical departments are now all on a full- 
time basis. As you know, Jim Growden 
is professor of oncology here. Last fall 
Dr. Hayden C. Nicholson, formerly secre- 
tary of the National Research Council, 
came here as dean. In general the fu- 
ture of the school looks bright, particu- 
larly since the legislature finally pro- 
vided funds to begin construction of a 
model 400-bed Medical Center, as the 
core clinical facility. I believe that Dr. 
E. P. Gildea has given much consultative 
help to the establishment of our depart- 
ment. 
"At the moment we are looking par- 
ticularly for a full-time neurologist and 
would  welcome  applications. 
"Betty, Billy, Bob and I are already 
comfortably settled into this congenial 
city, and would welcome any of you who 
wish to see us at 5501 Grandview Road, 
Little Rock. Drop us a line, Sincerely 
yours, Bill Reese." 
1913 
Edward H. Dunn has been transferred 
to A.N.S. Hospital in Tanana, Alaska. 
Hans-Karl Stauss can be reached at 
1200 N. State St., Jackson, Miss. 
Glenn L. McElroy is now at Shriner's 
Hospital for Crippled Children in St. 
Louis, where he will be until he enters 
private  practice this  coming  December. 
1911 
Marvin T. Pursell was a visitor to St. 
Louis early in April and stopped by the 
Alumni Office. He is doing general prac- 
tice in Dinuba, California. 
1915 
Samuel B. Guze is a fellow in psy- 
chiatry in the Division of Psychosomatic 
Medicine at W. U. School of Medicine. 
Edmund V. Cowdry, Jr., is a fellow in 
psychiatry on the Medical School staff 
and lives at 14 N. Kingshighway Blvd. 
William F. Andrew recently moved to 
3410 Tulane Dr., University Hills, West 
Hyattsville, Md., from Richmond, Mo. 
Marshall B. Conrad has moved to 7018 
Southland Ave., St. Louis. 
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The address of Betty Ben Geren is 372 
Longwood Avenue, Boston, Mass. 
1946 
Theodore J. Smith is now a captain in 
the IT. S. Air Force and is stationed at 
Station Hospital, Randolph Field, Texes, 
where he is chief of medical service. 
Before entering service in January, he 
was on the staff of Scott and White Clinic 
in Temple, Texas, in the department of 
internal medicine. 
Garrett Deane is resident in pediatrics 
at University Hospital, Baltimore, Md. 
He stopped in the alumni office recently 
during a visit to St. Louis. 
1947 
Paul F. Brown is at Pfeiffer Memorial 
Hospital, Clinica Americana, Cajon 9, 
La Paz, Bolivia. Before moving to La 
Paz, he was in training at Fresno County 
(Calif.) General Hospital. 
■.-:;; 
Jack A. Gregory is at Huntington Me- 
morial Hospital in Pasadena, Calif. 
H. Glenn Kellogg is stationed at U.S. 
Naval Hospital, San Diego, Calif. On 
January 13, he was married to Ensign 
Dorothy Zulick of Philadelphia, who is a 
navy nurse and also is at the Naval 
Hospital. 
1948 
Robert Friedman now lives at 4616 
Lindell Blvd., in St. Louis. 
Robert W. Petty is on active duty as 
senior medical officer on a naval trans- 
port ship plying the Pacific. His home 
address is 1305-27th St., Ogden, Utah. 
Duane R. Taylor is in his second year 
of residency at Jefferson Barracks Vet- 
erans Hospital. His home address is 815 
Dugan, Jefferson Barracks 23, Mo. 
Jn iHemnrtam 
1883 
Brice Edwards of Richmond Heights, 
Mo., passed away recently. 
1889 
John D. Kessenger of Salt Lake City, 
Utah, passed away last fall at the age 
of 85. 
1891 
T. C. Richards of Fayette, Mo., passed 
away recently. 
1892 
Harry Sturgeon Crossen, widely-known 
St. Louis gynecologist, died March 10 at 
the home of his son, Dr. Robert J. Cros- 
sen, at the age of 82 years. Dr. Crossen, 
who was professor emeritus of obstetrics- 
gynecology on the Medical School staff, 
had been ill for a long while. He joined 
the Washington U. medical staff in 1901 
and was chief of the gynecological dis- 
pensary at the old Washington Univer- 
sity Hospital from 1901 to 1911.   He was 
associate on the medical school staff 
until 1934, when he became emeritus pro- 
fessor. Dr. Crossen was author of sev- 
eral textbooks which are still widely 
used in medical schools. In 1940, he was 
honored at a testimonial dinner for his 
40 years of service with Washington Uni- 
versity, and the oil painting of him which 
now hangs in the Medical School Library 
was presented to the University at that 
time. 
1893 
Cornelius A. Mann of Glendale, Calif., 
passed away recently at the age of 79. 
1895 
Albert H. Thornburgh died August 15, 
1950, at the age of 80, in West Plains, Mo. 
1897 
William 1). Francis of Lampasas, Texas, 
passed away recently at the age of 97 in 
Austin,  Tex.   He was  92 years  old and 
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had   served   as   city   and   county   health 
officer of Lampasas. 
1898 
William   H.  Hays,  of  Hannibal,   Mo., 
Mo., passed away recently. 
1903 
Carl Althans, who had practiced in St. 
Louis for 46 years, passed away April 
1 of a heart ailment at his home, 3248 
Lafayette Ave. He was 69 years old and 
had maintained offices in his home since 
entering private practice 46 years ago. 
1904 
Harry L. Jones, who was associate pro- 
fessor of medicine at the  University of 
Kansas,  died  in  Kansas  City  December 
13, 1950, at the age of 73. 
1905 
Arthur M. Gregg of Joplin, Mo., passed 
away December 14, 1950, at the age of 66. 
1910 
T. P. Gronoway of Macon, Mo., died 
March 4, 1951. 
1911 
John F. Beatty of Everett, Wash., 
passed away December 15, 1950, at the 
age of 61. 
1920 
W. Roger Moore, a pediatrician prac- 
ticing in St. Joseph, Mo., died August 16, 
1950, at the age of 54. He was past presi- 
dent of the Buchanan County (Mo.) Medi- 
cal Society. 
1935 
Robert H. Swinney of Portland, Oregon, 
was drowned in a fishing accident on the 
Lewis River, February 8, 1951. Dr. Swin- 
ney had practiced surgery in Portland 
since 1941, and is survived by his widow, 
Mrs. Ruth Erlanger Swinney, and two 
daughters, Peggy, 7, and Patsy, 5. 
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